QUARTERLY REPORT

Q3 2026 — Quarterly report on Form 10-Q

Q3 2026PDF · 66 pages4.7 MB
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended October 2, 2026
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from 	to
Commission File Number: 001-02217
COCA COLA CO
(Exact name of Registrant as specified in its charter)
Delaware 	58-0628465
(State or other jurisdiction of incorporation or organization) 	(I.R.S. Employer Identification No.)
One Coca-Cola Plaza
Atlanta, Georgia 	30313
(Address of principal executive offices) 	(Zip Code)
Registrant’s telephone number, including area code: (404) 676-2121
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common Stock, $0.25 Par Value 	KO 	New York Stock Exchange
1.125% Notes Due 2027 	KO27 	New York Stock Exchange
0.125% Notes Due 2029 	KO29A 	New York Stock Exchange
0.125% Notes Due 2029 	KO29B 	New York Stock Exchange
0.400% Notes Due 2030 	KO30B 	New York Stock Exchange
1.250% Notes Due 2031 	KO31 	New York Stock Exchange
3.125% Notes Due 2032 	KO32 	New York Stock Exchange
0.375% Notes Due 2033 	KO33 	New York Stock Exchange
0.500% Notes Due 2033 	KO33A 	New York Stock Exchange
1.625% Notes Due 2035 	KO35 	New York Stock Exchange
1.100% Notes Due 2036 	KO36 	New York Stock Exchange
0.950% Notes Due 2036 	KO36A 	New York Stock Exchange
3.375% Notes Due 2037 	KO37 	New York Stock Exchange
0.800% Notes Due 2040 	KO40B 	New York Stock Exchange
1.000% Notes Due 2041 	KO41 	New York Stock Exchange
3.500% Notes Due 2044 	KO44 	New York Stock Exchange
3.750% Notes Due 2053 	KO53 	New York Stock Exchange
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes ☒ No ☐

-- 1 of 66 --

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth
company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer 	☒ 	Accelerated filer 	☐
Non-accelerated filer 	☐ 	Smaller reporting company 	☐
Emerging growth company 	☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 	☐
Indicate by check mark if the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock as of the latest practicable date.
Class of Common Stock 	Shares Outstanding as of October 26, 2026
$0.25 Par Value 	4,301,902,335

-- 2 of 66 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
Table of Contents
Page
Forward-Looking Statements 	1
Part I. Financial Information
Item 1. 	Financial Statements 	2
Consolidated Statements of Income — Three and Nine Months Ended October 2, 2026 and
September 26, 2025 	2
Consolidated Statements of Comprehensive Income — Three and Nine Months Ended October 2, 2026 and September 26, 2025 	3
Consolidated Balance Sheets — October 2, 2026 and December 31, 2025 	4
Consolidated Statements of Cash Flows — Nine Months Ended October 2, 2026 and September 26, 2025 	5
Notes to Consolidated Financial Statements 	6
Item 2. 	Management’s Discussion and Analysis of Financial Condition and Results of Operations 	33
Item 3. 	Quantitative and Qualitative Disclosures About Market Risk 	48
Item 4. 	Controls and Procedures 	48
Part II. Other Information
Item 1. 	Legal Proceedings 	48
Item 1A. 	Risk Factors 	51
Item 2. 	Unregistered Sales of Equity Securities and Use of Proceeds 	51
Item 5. 	Other Information 51
Item 6. 	Exhibits 	51
Signatures 	55

-- 3 of 66 --

FORWARD-LOOKING STATEMENTS
This report contains information that may constitute “forward-looking statements.” Generally, the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,”
“will” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions
does not mean that a statement is not forward-looking. All statements that address operating performance, events or developments that we expect or anticipate will occur in the
future are forward-looking statements. Management believes that these forward-looking statements are reasonable as and when made. However, caution should be taken not to
place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. Our Company undertakes no obligation to publicly
update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking
statements are subject to certain risks and uncertainties that could cause our Company’s actual results to differ materially from historical experience and our present
expectations or projections. These risks and uncertainties include, but are not limited to, the possibility that the assumptions used to calculate our estimated aggregate
incremental tax and interest liability related to the potential unfavorable outcome of the ongoing tax dispute with the United States Internal Revenue Service could significantly
change; those described in Part II, “Item 1A. Risk Factors” and elsewhere in this report and in our Annual Report on Form 10-K for the year ended December 31, 2025; and
those described from time to time in our future reports filed with the Securities and Exchange Commission.
1

-- 4 of 66 --

Part I. Financial Information
Item 1. Financial Statements
THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(In millions except per share data)
Three Months Ended 	Nine Months Ended
October 2,
2026 September 26,
2025 October 2,
2026 September 26,
2025
Net Operating Revenues 	$ 	13,380 $ 	12,455 	$ 	39,232 $ 	36,119
Cost of goods sold 	4,930 	4,797 	14,515 	13,674
Gross Profit 	8,450 	7,658 	24,717 	22,445
Selling, general and administrative expenses 	3,975 	3,618 	11,167 	10,322
Other operating charges 	10 	58 	54 	202
Operating Income 	4,465 	3,982 	13,496 	11,921
Interest income 	224 	185 	644 	553
Interest expense 	354 	391 	1,098 	1,223
Equity income (loss) — net 	653 	644 	1,641 	1,556
Other income (loss) — net 	(155) 	(237) 	236 	229
Income Before Income Taxes 	4,833 	4,183 	14,919 	13,036
Income taxes 	777 	500 	2,459 	2,215
Consolidated Net Income 	4,056 	3,683 	12,460 	10,821
Less: Net income (loss) attributable to noncontrolling interests 	47 	(13) 	102 	(15)
Net Income Attributable to Shareowners of The Coca-Cola Company 	$ 	4,009 $ 	3,696 	$ 	12,358 $ 	10,836
Basic Net Income Per Share 	$ 	0.93 $ 	0.86 	$ 	2.87 $ 	2.52
Diluted Net Income Per Share $ 	0.93 $ 	0.86 	$ 	2.86 $ 	2.51
Average Shares Outstanding — Basic 	4,303 	4,303 	4,302 	4,303
Effect of dilutive securities 	11 	10 	11 	11
Average Shares Outstanding — Diluted 	4,314 	4,313 	4,313 	4,314
Calculated based on net income attributable to shareowners of The Coca-Cola Company.
Refer to Notes to Consolidated Financial Statements.
1
1
1
2

-- 5 of 66 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In millions)
Three Months Ended 	Nine Months Ended
October 2,
2026 September 26,
2025 October 2,
2026 September 26,
2025
Consolidated Net Income 	$ 	4,056 $ 	3,683 	$ 	12,460 $ 	10,821
Other Comprehensive Income:
Net foreign currency translation adjustments 	(668) 	437 	(311) 	2,159
Net gains (losses) on derivatives 	77 	152 	208 	(449)
Net change in unrealized gains (losses) on available-for-sale debt securities 	(7) 	9 	(21) 	32
Net change in pension and other postretirement benefit liabilities 	87 	7 	130 	27
Total Comprehensive Income 	3,545 	4,288 	12,466 	12,590
Less: Comprehensive income (loss) attributable to noncontrolling interests 	— 	(214) 	67 	(137)
Total Comprehensive Income Attributable to Shareowners of The Coca-Cola Company 	$ 	3,545 $ 	4,502 	$ 	12,399 $ 	12,727
Refer to Notes to Consolidated Financial Statements.
3

-- 6 of 66 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In millions except par value)
October 2,
2026
December 31,
2025
ASSETS
Current Assets
Cash and cash equivalents 	$ 	13,454 $ 	10,270
Short-term investments 	231 	3,602
Total Cash, Cash Equivalents and Short-Term Investments 	13,685 	13,872
Marketable securities 	2,910 	1,934
Trade accounts receivable, less allowances of $514 and $495, respectively 	3,571 	3,038
Inventories 	4,410 	4,425
Prepaid expenses and other current assets 	2,475 	2,433
Assets held for sale 	6,275 	5,342
Total Current Assets 	33,326 	31,044
Equity method investments 	20,710 	20,235
Deferred income tax assets 	1,086 	1,206
Property, plant and equipment, less accumulated depreciation of $9,019 and $9,119, respectively 	9,485 	9,613
Trademarks with indefinite lives 	12,459 	12,531
Goodwill 	15,408 	15,491
Other noncurrent assets 	15,476 	14,696
Total Assets 	$ 	107,950 $ 	104,816
LIABILITIES AND EQUITY
Current Liabilities
Accounts payable and accrued expenses 	$ 	15,633 $ 	14,813
Loans and notes payable 	73 	1,551
Current maturities of long-term debt 	4,923 	1,822
Accrued income taxes 	577 	525
Liabilities held for sale 	3,003 	2,570
Total Current Liabilities 	24,209 	21,281
Long-term debt 	36,623 	42,119
Other noncurrent liabilities 	4,678 	4,735
Deferred income tax liabilities 	2,907 	2,406
The Coca-Cola Company Shareowners’ Equity
Common stock, $0.25 par value; authorized — 11,200 shares; issued — 7,040 shares 	1,760 	1,760
Capital surplus 	20,894 	20,581
Reinvested earnings 	85,898 	80,382
Accumulated other comprehensive income (loss) 	(14,090) 	(14,131)
Treasury stock, at cost — 2,738 and 2,738 shares, respectively 	(57,090) 	(56,423)
Equity Attributable to Shareowners of The Coca-Cola Company 	37,372 	32,169
Equity attributable to noncontrolling interests 	2,161 	2,106
Total Equity 	39,533 	34,275
Total Liabilities and Equity 	$ 	107,950 $ 	104,816
Refer to Notes to Consolidated Financial Statements.
4

-- 7 of 66 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
Nine Months Ended
October 2,
2026 September 26,
2025
Operating Activities
Consolidated net income 	$ 	12,460 $ 	10,821
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization 	783 	814
Stock-based compensation expense 	194 	204
Deferred income taxes 	457 	496
Equity (income) loss — net of dividends 	(1,013) 	(859)
Foreign currency adjustments 	106 	127
Significant (gains) losses — net 	(61) 	(396)
Other operating charges 	— 	38
Other items 	43 	447
Net change in operating assets and liabilities 	(498) 	(8,040)
Net Cash Provided by (Used in) Operating Activities 	12,471 	3,652
Investing Activities
Purchases of investments 	(3,706) 	(3,292)
Proceeds from disposals of investments 	5,952 	4,300
Acquisitions of businesses, equity method investments and nonmarketable securities 	(204) 	(356)
Proceeds from disposals of businesses, equity method investments and nonmarketable securities 	1 	1,020
Purchases of property, plant and equipment 	(1,063) 	(1,230)
Proceeds from disposals of property, plant and equipment 	43 	21
Collateral (paid) received associated with hedging activities — net 	(133) 	300
Other investing activities 	271 	214
Net Cash Provided by (Used in) Investing Activities 	1,161 	977
Financing Activities
Issuances of loans, notes payable and long-term debt 	19 	4,854
Payments of loans, notes payable and long-term debt 	(3,165) 	(4,166)
Issuances of stock 	355 	243
Purchases of stock for treasury 	(900) 	(644)
Dividends 	(6,842) 	(4,391)
Proceeds from sale of a noncontrolling interest 	— 	1,277
Other financing activities 	(13) 	(261)
Net Cash Provided by (Used in) Financing Activities 	(10,546) 	(3,088)
Effect of Exchange Rate Changes on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 	35 	335
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents during the period 	3,121 	1,876
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period 	11,010 	11,488
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents at End of Period 	14,131 	13,364
Less: Restricted cash and restricted cash equivalents at end of period 	677 	632
Cash and Cash Equivalents at End of Period 	$ 	13,454 $ 	12,732
Refer to Notes to Consolidated Financial Statements.
5

-- 8 of 66 --

THE COCA-COLA COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S.
GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. They do not include all information and notes required by
U.S. GAAP for complete financial statements. However, except as disclosed herein, there has been no material change in the information disclosed in the Notes to Consolidated
Financial Statements included in the Annual Report on Form 10-K of The Coca-Cola Company for the year ended December 31, 2025. Certain other amounts in the prior year’s
consolidated financial statements and notes have been revised to conform to the current year presentation.
When used in these notes, the terms “The Coca-Cola Company,” “Company,” “we,” “us” and “our” mean The Coca-Cola Company and all entities included in our consolidated
financial statements. In the opinion of management, all adjustments (including normal recurring accruals) considered necessary for a fair presentation have been included.
Operating results for the three and nine months ended October 2, 2026 are not necessarily indicative of the results that may be expected for the year ending December 31, 2026.
Sales of our ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters typically accounting for the highest sales volumes. The volume of
sales in the beverage business may be affected by weather conditions.
Each of our quarterly reporting periods, other than the fourth quarter, ends on the Friday closest to the last day of the corresponding quarterly calendar period. The third quarter
of 2026 and the third quarter of 2025 ended on October 2, 2026 and September 26, 2025, respectively. Our fourth quarter and our fiscal year end on December 31 regardless of
the day of the week on which December 31 falls.
Advertising Costs
The Company’s accounting policy related to advertising costs for annual reporting purposes is to expense production costs of print, radio, television and other advertisements as
of the first date the advertisements take place. All other marketing expenditures are expensed in the annual period in which the expenditure is incurred.
For quarterly reporting purposes, we allocate our estimated full year marketing expenditures that benefit multiple quarters to each of those quarters. We use the proportion of
each quarter’s actual unit case volume to the estimated full year unit case volume as the basis for the allocation. This methodology results in our marketing expenditures being
recognized at a standard rate per unit case. At the end of each quarter, we review our estimated full year unit case volume and our estimated full year marketing expenditures
that benefit multiple quarters in order to evaluate if a change in estimate is necessary. The impact of any change in the full year estimate is recognized in the quarter in which
the change in estimate occurs. Our full year marketing expenditures are not impacted by this interim accounting policy.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
We classify time deposits and other investments that are highly liquid and have maturities of three months or less at the date of purchase as cash equivalents or restricted cash
equivalents, as applicable. Restricted cash and restricted cash equivalents generally consist of amounts held by our captive insurance companies, which are included in the line
item other noncurrent assets in our consolidated balance sheet, and when applicable, cash and cash equivalents related to assets held for sale are included in the line item assets
held for sale in our consolidated balance sheet. We manage our exposure to counterparty credit risk through specific minimum credit standards, diversification of counterparties
and procedures to monitor our concentrations of credit risk. Refer to Note 2 for additional information on our assets held for sale and Note 4 for additional information on our
captive insurance companies.
The following tables provide a summary of cash, cash equivalents, restricted cash and restricted cash equivalents that constitute the total amounts shown in our consolidated
statements of cash flows (in millions):
October 2,
2026
December 31,
2025
Cash and cash equivalents 	$ 	13,454 $ 	10,270
Restricted cash and restricted cash equivalents 	677 	740
Cash, cash equivalents, restricted cash and restricted cash equivalents 	$ 	14,131 $ 	11,010
6

-- 9 of 66 --

September 26,
2025
December 31,
2024
Cash and cash equivalents 	$ 	12,732 $ 	10,828
Restricted cash and restricted cash equivalents 	632 	660
Cash, cash equivalents, restricted cash and restricted cash equivalents 	$ 	13,364 $ 	11,488
NOTE 2: ACQUISITIONS AND DIVESTITURES
Acquisitions
Our Company’s acquisitions of businesses, equity method investments and nonmarketable securities totaled $204 million and $356 million during the nine months ended
October 2, 2026 and September 26, 2025, respectively. The activity during the nine months ended October 2, 2026 and September 26, 2025 included additional investments of
$112 million and $54 million, respectively, in an equity method investee in Japan. The activity during the nine months ended October 2, 2026 and September 26, 2025 also
included $75 million and $271 million, respectively, of investments in alternative energy limited partnerships. Refer to Note 14 for additional information on these investments.
Divestitures
Proceeds from disposals of businesses, equity method investments and nonmarketable securities totaled $1 million and $1,020 million during the nine months ended October 2,
2026 and September 26, 2025, respectively. In March 2025, the Company sold a portion of our ownership interest in Coca-Cola Europacific Partners plc (“CCEP”), an equity
method investee, for which we received cash proceeds of $741 million and recognized a gain of $331 million. In May 2025, the Company refranchised its bottling operations in
certain territories in India that were held for sale as of December 31, 2024, for which we received net cash proceeds of $218 million and recognized a gain of $102 million.
These gains were recorded in the line item other income (loss) — net in our consolidated statement of income.
Assets and Liabilities Held for Sale
In October 2025, the Company entered into a definitive agreement to sell a portion of our interest in our bottling operations in Africa to Coca-Cola HBC AG (“CCHBC”), an
equity method investee. Closing is subject to various regulatory approvals and is expected by the end of 2026, upon which we will deconsolidate these bottling operations. We
have also agreed to a separate option arrangement for CCHBC to acquire the Company’s remaining 25% ownership interest within a six-year period from closing. As these
operations met the criteria to be classified as held for sale, during the year ended December 31, 2025, we were required to record the related assets and liabilities at the lower of
carrying value or fair value less any costs to sell based on the estimated proceeds. This resulted in an impairment charge of $1,274 million, primarily due to the negative net
foreign currency translation adjustments that will be reclassified into income upon sale. During the three and nine months ended October 2, 2026, we recorded a gain to reduce
this impairment charge by $5 million and $61 million, respectively, based on management’s revised estimates. These amounts were recorded in the line item other income (loss)
— net in our consolidated statements of income.
During the three months ended October 2, 2026, the Company’s bottling operations in Singapore, Malaysia and Myanmar met the criteria to be classified as held for sale. As a
result, we were required to record the related assets and liabilities at the lower of carrying value or fair value less any costs to sell based on the estimated proceeds. As the fair
value of the disposal group less any costs to sell exceeded the carrying value, the related assets and liabilities were recorded at their carrying values. Closings are subject to
various regulatory approvals and are expected by mid 2027.
7

-- 10 of 66 --

The following table presents information related to the major classes of assets and liabilities that were classified as held for sale in our consolidated balance sheets (in millions):
October 2,
2026
December 31,
2025
Cash, cash equivalents and short-term investments 	$ 	243 $ 	178
Trade accounts receivable, less allowances 	415 	389
Inventories 	630 	466
Prepaid expenses and other current assets 	440 	147
Equity method investments 	4 	5
Deferred income tax assets 	49 	46
Property, plant and equipment — net 	2,243 	1,964
Trademarks with indefinite lives 	3 	2
Goodwill 	3,347 	3,350
Other noncurrent assets 	102 	60
Allowance for reduction of assets held for sale 	(1,201) 	(1,265)
Assets held for sale 	$ 	6,275 $ 	5,342
Accounts payable and accrued expenses 	$ 	1,223 $ 	816
Loans and notes payable 	145 	187
Current maturities of long-term debt 	417 	398
Accrued income taxes 	25 	5
Long-term debt 	844 	850
Other noncurrent liabilities 	159 	154
Deferred income tax liabilities 	190 	160
Liabilities held for sale 	$ 	3,003 $ 	2,570
NOTE 3: NET OPERATING REVENUES
The following tables present net operating revenues disaggregated between the United States and International and further by line of business (in millions):
United States 	International 	Total
Three Months Ended October 2, 2026
Concentrate operations 	$ 	2,475 $ 	5,724 $ 	8,199
Finished product operations 	2,784 	2,397 	5,181
Total 	$ 	5,259 $ 	8,121 $ 	13,380
Three Months Ended September 26, 2025
Concentrate operations 	$ 	2,430 $ 	5,069 $ 	7,499
Finished product operations 	2,688 	2,268 	4,956
Total 	$ 	5,118 $ 	7,337 $ 	12,455
United States 	International 	Total
Nine Months Ended October 2, 2026
Concentrate operations 	$ 	7,089 $ 	16,641 $ 	23,730
Finished product operations 	8,175 	7,327 	15,502
Total 	$ 	15,264 $ 	23,968 $ 	39,232
Nine Months Ended September 26, 2025
Concentrate operations 	$ 	6,727 $ 	14,984 $ 	21,711
Finished product operations 	7,579 	6,829 	14,408
Total 	$ 	14,306 $ 	21,813 $ 	36,119
Refer to Note 16 for disclosures of net operating revenues by operating segment and Corporate.
8

-- 11 of 66 --

NOTE 4: INVESTMENTS
Equity Securities
The carrying values of our equity securities were included in the following line items in our consolidated balance sheets (in millions):
Fair Value with Changes
Recognized in Income
Measurement Alternative
— No Readily
Determinable Fair Value
October 2, 2026
Marketable securities 	$ 	560 $ 	—
Other noncurrent assets 	2,670 	120
Total equity securities 	$ 	3,230 $ 	120
December 31, 2025
Marketable securities 	$ 	489 $ 	—
Other noncurrent assets 	2,100 	44
Total equity securities 	$ 	2,589 $ 	44
The calculation of net unrealized gains and losses recognized during the period related to equity securities still held at the end of the period is as follows (in millions):
Three Months Ended 	Nine Months Ended
October 2,
2026
September 26,
2025
October 2,
2026
September 26,
2025
Net gains (losses) recognized during the period related to equity securities 	$ 	40 $ 	165 	$ 	345 $ 	315
Less: Net gains (losses) recognized during the period related to equity securities sold
during the period 	(13) 	17 	33 	38
Net unrealized gains (losses) recognized during the period related to equity securities still
held at the end of the period 	$ 	53 $ 	148 	$ 	312 $ 	277
Debt Securities
Our debt securities consisted of the following (in millions):
Gross Unrealized 	Estimated
Fair Value	Cost 	Gains 	Losses
October 2, 2026
Trading securities $ 	47 $ 	— $ 	(1) $ 	46
Available-for-sale securities 2,731 	18 	(77) 	2,672
Total debt securities $ 	2,778 $ 	18 $ 	(78) $ 	2,718
December 31, 2025
Trading securities $ 	49 $ 	1 $ 	— $ 	50
Available-for-sale securities 1,816 	23 	(65) 	1,774
Total debt securities $ 	1,865 $ 	24 $ 	(65) $ 	1,824
The estimated fair value as of October 2, 2026 includes $2,115 million of Brazilian government bonds with a cost of $2,163 million and gross unrealized losses of $48 million and, as of
December 31, 2025, includes $1,207 million of Brazilian government bonds with a cost of $1,255 million, gross unrealized gains of $1 million and gross unrealized losses of $49 million.
1
1
1
9

-- 12 of 66 --

The carrying values of our debt securities were included in the following line items in our consolidated balance sheets (in millions):
October 2, 2026 	December 31, 2025
Trading Securities Available-for-Sale
Securities 	Trading Securities Available-for-Sale
Securities
Marketable securities $ 	46 $ 	2,304 	$ 	50 $ 	1,395
Other noncurrent assets — 	368 	— 	379
Total debt securities 	$ 	46 $ 	2,672 	$ 	50 $ 	1,774
The contractual maturities of these available-for-sale debt securities as of October 2, 2026 were as follows (in millions):
Cost Estimated
Fair Value
Within 1 year 	$ 	880 $ 	863
After 1 year through 5 years 	1,635 	1,607
After 5 years through 10 years 	33 	34
After 10 years 	183 	168
Total 	$ 	2,731 $ 	2,672
The Company expects that actual maturities may differ from the contractual maturities above because borrowers have the right to call or prepay certain obligations.
The sale and/or maturity of available-for-sale debt securities resulted in the following realized activity (in millions):
Three Months Ended 	Nine Months Ended
October 2,
2026
September 26,
2025
October 2,
2026
September 26,
2025
Gross gains 	$ 	1 $ 	— 	$ 	3 $ 	3
Gross losses 	(2) 	(1) 	(5) 	(5)
Proceeds 	82 	397 	653 	604
Captive Insurance Companies
In accordance with local insurance regulations, our consolidated captive insurance companies are required to meet and maintain minimum solvency capital requirements. The
Company elected to invest a majority of its solvency capital in a portfolio of marketable equity and debt securities. These securities are included in the disclosures above. The
Company uses one of our consolidated captive insurance companies to reinsure group annuity insurance contracts that cover the obligations of certain of our European and
Canadian pension plans. This captive’s solvency capital funds included total equity and debt securities of $2,890 million and $2,356 million as of October 2, 2026 and
December 31, 2025, respectively, which were classified in the line item other noncurrent assets in our consolidated balance sheets because the assets were not available to
satisfy our current obligations.
NOTE 5: INVENTORIES
Inventories consisted of the following (in millions):
October 2,
2026
December 31,
2025
Raw materials and packaging 	$ 	2,562 $ 	2,708
Finished goods 	1,483 	1,375
Other 	365 	342
Total inventories 	$ 	4,410 $ 	4,425
10

-- 13 of 66 --

NOTE 6: HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
The following table presents the fair values of the Company’s derivative instruments that were designated and qualified as part of a hedging relationship (in millions):
Fair Value
Derivatives Designated as Hedging Instruments 	Financial Statement Line Item Impacted October 2,
2026 December 31,
2025
Assets:
Foreign currency contracts 	Prepaid expenses and other current assets 	$ 	252 $ 	125
Foreign currency contracts 	Other noncurrent assets 	50 	31
Interest rate contracts 	Other noncurrent assets 	149 	142
Total assets 	$ 	451 $ 	298
Liabilities:
Foreign currency contracts 	Accounts payable and accrued expenses 	$ 	50 $ 	205
Foreign currency contracts 	Other noncurrent liabilities 	28 	28
Commodity contracts 	Accounts payable and accrued expenses 	2 	9
Interest rate contracts 	Accounts payable and accrued expenses 	15 	17
Interest rate contracts 	Other noncurrent liabilities 	844 	700
Total liabilities 	$ 	939 $ 	959
The following table presents the fair values of the Company’s derivative instruments that were not designated as hedging instruments (in millions):
Fair Value
Derivatives Not Designated as Hedging Instruments 	Financial Statement Line Item Impacted
October 2,
2026 	December 31, 2025
Assets:
Foreign currency contracts 	Prepaid expenses and other current assets 	$ 	139 $ 	115
Foreign currency contracts 	Other noncurrent assets 	52 	18
Foreign currency contracts 	Assets held for sale 	2 	—
Commodity contracts 	Prepaid expenses and other current assets 	103 	7
Commodity contracts 	Other noncurrent assets 	6 	—
Commodity contracts 	Assets held for sale 	9 	3
Other derivative instruments 	Prepaid expenses and other current assets 	5 	—
Total assets 	$ 	316 $ 	143
Liabilities:
Foreign currency contracts 	Accounts payable and accrued expenses 	$ 	161 $ 	66
Foreign currency contracts 	Other noncurrent liabilities 	74 	5
Foreign currency contracts 	Liabilities held for sale 	1 	5
Commodity contracts 	Accounts payable and accrued expenses 	12 	10
Commodity contracts 	Other noncurrent liabilities 	— 	1
Commodity contracts 	Liabilities held for sale 	1 	1
Other derivative instruments 	Accounts payable and accrued expenses 	— 	2
Total liabilities 	$ 	249 $ 	90
All of the Company’s derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting
agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed
without reflecting the impact of master netting agreements and cash collateral. Refer to Note 15 for the net presentation of the Company’s derivative instruments and for
additional information related to the estimated fair value. We classify both the earnings and cash flow impact from these derivatives consistent with the underlying hedged item.
The settlement of derivatives that are part of our cash flow hedging, fair value hedging, and economic hedging strategies are classified as operating activities in our
consolidated statement of cash flows. The settlement of derivative instruments designated as hedges of net investments in foreign operations are classified as investing activities
in our consolidated statement of cash flows.
11

-- 14 of 66 --

Credit Risk Associated with Derivatives
We have established strict counterparty credit guidelines and enter into transactions only with financial institutions of investment grade or better. We monitor counterparty
exposures regularly and review any downgrade in credit rating immediately. If a downgrade in the credit rating of a counterparty were to occur, we have provisions requiring
collateral for substantially all of our transactions. To mitigate pre-settlement risk, minimum credit standards become more stringent as the duration of the derivative financial
instrument increases. In addition, the Company’s master netting agreements reduce credit risk by permitting the Company to net settle for transactions with the same
counterparty. To minimize the concentration of credit risk, we enter into derivative transactions with a portfolio of financial institutions. Furthermore, for certain derivative
financial instruments, the Company has agreements with counterparties that require collateral to be exchanged based on changes in the fair value of the instruments. The
Company classifies collateral payments and receipts as investing cash flows when the collateral account is in an asset position and as financing cash flows when the collateral
account is in a liability position. As a result of these factors, we consider the risk of counterparty default to be minimal.
Cash Flow Hedging Strategy
The Company uses cash flow hedges to minimize the variability in cash flows of assets or liabilities or forecasted transactions caused by fluctuations in foreign currency
exchange rates, commodity prices or interest rates. The changes in the fair values of derivatives designated as cash flow hedges are recorded in accumulated other
comprehensive income (loss) (“AOCI”) and are reclassified into the line item in our consolidated statement of income in which the hedged items are recorded in the same
period the hedged items affect earnings. The changes in the fair values of hedges that are determined to be ineffective are immediately reclassified from AOCI into income. The
maximum length of time for which the Company hedges its exposure to the variability in future cash flows is typically three years.
The Company maintains a foreign currency cash flow hedging program to reduce the risk that our U.S. dollar net cash inflows from sales outside the United States and U.S.
dollar net cash outflows from procurement activities will be adversely affected by fluctuations in foreign currency exchange rates. We enter into forward contracts and purchase
foreign currency options and collars (principally euro, British pound and Japanese yen) to hedge certain portions of forecasted cash flows denominated in foreign currencies.
When the U.S. dollar strengthens against the foreign currencies, the decline in the present value of future foreign currency cash flows is partially offset by gains in the fair value
of the derivative instruments. Conversely, when the U.S. dollar weakens, the increase in the present value of future foreign currency cash flows is partially offset by losses in
the fair value of the derivative instruments. The total notional values of derivatives that were designated and qualified for the Company’s foreign currency cash flow hedging
program were $11,041 million and $9,760 million as of October 2, 2026 and December 31, 2025, respectively.
The Company uses cross-currency swaps to hedge the changes in cash flows of certain of its foreign currency denominated debt and other monetary assets or liabilities due to
fluctuations in foreign currency exchange rates. For this hedging program, the Company recognizes in earnings each period the changes in carrying values of these foreign
currency denominated assets and liabilities due to fluctuations in exchange rates. The changes in fair values of the cross-currency swap derivatives are recorded in AOCI with
an immediate reclassification into income for the changes in fair values attributable to fluctuations in foreign currency exchange rates. The total notional value of derivatives
that were designated as cash flow hedges for the Company’s foreign currency denominated assets and liabilities was $557 million as of both October 2, 2026 and December 31,
2025.
The Company has entered into commodity futures contracts and other derivative instruments on various commodities to mitigate the price risk associated with forecasted
purchases of materials used in our manufacturing process. These derivative instruments were designated as part of the Company’s commodity cash flow hedging program. The
objective of this hedging program is to reduce the variability of cash flows associated with future purchases of certain commodities. The total notional values of derivatives that
were designated and qualified for this program were $48 million and $53 million as of October 2, 2026 and December 31, 2025, respectively.
Our Company monitors our mix of short-term debt and long-term debt regularly. We manage our risk related to interest rate fluctuations through the use of derivative financial
instruments. From time to time, the Company has entered into interest rate swap agreements and has designated these instruments as part of the Company’s interest rate cash
flow hedging program. The objective of this hedging program is to mitigate the risk of adverse changes in benchmark interest rates on the Company’s future interest payments.
The total notional values of derivatives that were designated and qualified for this program were $769 million and $1,786 million as of October 2, 2026 and December 31,
2025, respectively.
12

-- 15 of 66 --

The following tables present the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on other comprehensive income (“OCI”), AOCI
and income (in millions):
Gain (Loss)
Recognized
in OCI Financial Statement Line Item Impacted
Gain (Loss) Reclassified
from AOCI into Income
Three Months Ended October 2, 2026
Foreign currency contracts 	$ 	63 Net operating revenues 	$ 	(65)
Foreign currency contracts 	(1) Cost of goods sold 	9
Foreign currency contracts 	— Interest expense 	(1)
Foreign currency contracts 	4 Other income (loss) — net 	(10)
Commodity contracts 	(7) Cost of goods sold 	2
Interest rate contracts 	42 Interest expense 	—
Total 	$ 	101 	$ 	(65)
Three Months Ended September 26, 2025
Foreign currency contracts 	$ 	41 Net operating revenues 	$ 	(109)
Foreign currency contracts 	12 Cost of goods sold 	—
Foreign currency contracts 	— Interest expense 	(1)
Foreign currency contracts 	(6) Other income (loss) — net 	(1)
Commodity contracts 	4 Cost of goods sold 	—
Interest rate contracts 	— Interest expense 	(1)
Total 	$ 	51 	$ 	(112)
Gain (Loss)
Recognized
in OCI Financial Statement Line Item Impacted
Gain (Loss) Reclassified
from AOCI into Income
Nine Months Ended October 2, 2026
Foreign currency contracts 	$ 	72 Net operating revenues 	$ 	(199)
Foreign currency contracts 	17 Cost of goods sold 	14
Foreign currency contracts 	— Interest expense 	(3)
Foreign currency contracts 	1 Other income (loss) — net 	(25)
Commodity contracts 	39 Cost of goods sold 	32
Interest rate contracts 	41 Interest expense 	(2)
Total 	$ 	170 	$ 	(183)
Nine Months Ended September 26, 2025
Foreign currency contracts 	$ 	(729) Net operating revenues 	$ 	(137)
Foreign currency contracts 	(6) Cost of goods sold 	4
Foreign currency contracts 	— Interest expense 	(3)
Foreign currency contracts 	31 Other income (loss) — net 	67
Commodity contracts 	(6) Cost of goods sold 	(2)
Interest rate contracts 	(1) Interest expense 	(2)
Total 	$ 	(711) 	$ 	(73)
As of October 2, 2026, the Company estimates that it will reclassify into income during the next 12 months net gains of $71 million from the pretax amount recorded in AOCI
as the anticipated cash flows occur.
Fair Value Hedging Strategy
The Company uses interest rate swap agreements designated as fair value hedges to minimize exposure to changes in the fair value of fixed-rate debt that result from
fluctuations in benchmark interest rates. The Company also uses cross-currency interest rate swaps to hedge the changes in the fair value of foreign currency denominated debt
relating to fluctuations in foreign currency exchange rates and benchmark interest rates. The changes in the fair values of derivatives designated as fair value hedges and the
offsetting changes in the fair values of the hedged items are recognized in earnings. As a result, any difference is reflected in earnings as ineffectiveness. When a derivative is
no longer designated as a fair value hedge for any reason, including termination and maturity, the remaining unamortized difference between the carrying value of the hedged
item at that
13

-- 16 of 66 --

time and the face value of the hedged item is amortized into earnings over the remaining life of the hedged item, or immediately if the hedged item has matured or has been
extinguished. The total notional values of derivatives that were designated and qualified as fair value hedges of this type were $11,875 million and $13,674 million as of
October 2, 2026 and December 31, 2025, respectively.
The following table summarizes the pretax impact that changes in the fair values of derivatives designated as fair value hedges had on income (in millions):
Hedging Instruments and Hedged Items
Financial Statement Line Item
Impacted
Gain (Loss) Recognized in Income
Three Months Ended 	Nine Months Ended
October 2,
2026
September 26,
2025
October 2,
2026
September 26,
2025
Interest rate contracts 	Interest expense 	$ 	(165) $ 	26 	$ 	(176) $ 	274
Fixed-rate debt 	Interest expense 	172 	(19) 	189 	(265)
Net impact of fair value hedging instruments 	$ 	7 $ 	7 	$ 	13 $ 	9
The following table summarizes the amounts recorded in our consolidated balance sheets related to hedged items in fair value hedging relationships (in millions):
Cumulative Amount of Fair Value Hedging Adjustments
Carrying Values of
Hedged Items
Included in the Carrying Values of Hedged
Items
Remaining for Which Hedge Accounting Has
Been Discontinued
Balance Sheet Location of Hedged Items October 2,
2026 December 31,
2025 October 2,
2026 December 31,
2025 October 2,
2026 December 31,
2025
Current maturities of long-term debt 	$ 	1,687 $ 	1,491 	$ 	(16) $ 	(10) 	$ 	6 $ 	—
Long-term debt 	9,450 	11,648 	(856) 	(705) 	66 	97
Cumulative amount of fair value hedging adjustments does not include changes due to foreign currency exchange rate fluctuations.
Hedges of Net Investments in Foreign Operations Strategy
The Company uses forward contracts and a portion of its foreign currency denominated debt, a non-derivative financial instrument, to protect the value of our net investments
in a number of foreign operations. In 2025, the Company changed its method for assessing the effectiveness of derivative financial instruments designated as net investment
hedges to include only the changes in fair value attributable to changes in foreign currency spot rates. The changes in the fair values of the effective portion of the derivative
financial instruments are recognized in net foreign currency translation adjustments, a component of AOCI, to offset the changes in the values of the net investments being
hedged. The initial value and subsequent changes in fair value of the excluded component are amortized into earnings over the life of the hedging instrument. The Company
recorded net gains of $8 million and $23 million for the three and nine months ended October 2, 2026, respectively, and a net gain of $8 million for both the three and nine
months ended September 26, 2025, related to the amortization of the excluded component. These amounts were recognized in interest expense in our consolidated statements of
income. For non-derivative financial instruments that are designated and qualify as hedges of net investments in foreign operations, the changes in the carrying values of the
designated portions of the non-derivative financial instruments due to fluctuations in foreign currency exchange rates are recorded in net foreign currency translation
adjustments. Any ineffective portions of net investment hedges are reclassified from AOCI into income during the period of change.
The following table summarizes the notional values and pretax impact of changes in the fair values of instruments designated as net investment hedges (in millions):
Notional Values 	Gain (Loss) Recognized in OCI
as of 	Three Months Ended 	Nine Months Ended
October 2,
2026
December 31,
2025
October 2,
2026
September 26,
2025
October 2,
2026
September 26,
2025
Foreign currency contracts 	$ 	2,926 $ 	1,067 	$ 	(4) $ 	12 	$ 	(14) $ 	11
Foreign currency denominated debt 	12,941 	14,998 	190 	23 	586 	(1,721)
Total 	$ 	15,867 $ 	16,065 	$ 	186 $ 	35 	$ 	572 $ 	(1,710)
The Company did not reclassify any gains or losses during the three and nine months ended October 2, 2026, or the three and nine months ended September 26, 2025.
1
1
14

-- 17 of 66 --

Economic (Non-Designated) Hedging Strategy
In addition to derivative instruments that have been designated and qualify for hedge accounting, the Company also uses certain derivatives as economic hedges of foreign
currency, interest rate and commodity exposure. Although these derivatives were not designated and/or did not qualify for hedge accounting, they are effective economic
hedges. The changes in the fair values of economic hedges are immediately recognized in earnings.
The Company uses foreign currency economic hedges to offset the earnings impact that fluctuations in foreign currency exchange rates have on certain monetary assets and
liabilities denominated in nonfunctional currencies. The changes in the fair values of economic hedges used to offset those monetary assets and liabilities are immediately
recognized in earnings in the line item other income (loss) — net in our consolidated statement of income. In addition, we use foreign currency economic hedges to minimize
the variability in cash flows associated with fluctuations in foreign currency exchange rates, including those related to certain acquisition and divestiture activities. The changes
in the fair values of economic hedges used to offset the variability in U.S. dollar net cash flows are immediately recognized in earnings in the line items net operating revenues,
cost of goods sold or other income (loss) — net in our consolidated statement of income, as applicable. The total notional values of derivatives related to our foreign currency
economic hedges were $12,582 million and $9,744 million as of October 2, 2026 and December 31, 2025, respectively.
The Company also uses certain derivatives as economic hedges to mitigate the price risk associated with the purchase of materials used in the manufacturing process and
vehicle fuel. The changes in the fair values of these economic hedges are immediately recognized in earnings in the line items net operating revenues, cost of goods sold, or
selling, general and administrative expenses in our consolidated statement of income, as applicable. The total notional values of derivatives related to our economic hedges of
this type were $807 million and $482 million as of October 2, 2026 and December 31, 2025, respectively.
The following tables present the pretax impact that changes in the fair values of derivatives not designated as hedging instruments had on income (in millions):
Derivatives Not Designated as Hedging Instruments 	Financial Statement Line Item Impacted
Gain (Loss)
Recognized in Income
Three Months Ended
October 2,
2026
September 26,
2025
Foreign currency contracts 	Net operating revenues 	$ 	4 $ 	1
Foreign currency contracts 	Cost of goods sold 	(6) 	28
Foreign currency contracts 	Other income (loss) — net 	(52) 	58
Commodity contracts 	Cost of goods sold 	112 	3
Other derivative instruments 	Selling, general and administrative expenses 	3 	4
Other derivative instruments 	Other income (loss) — net 	(2) 	—
Total 	$ 	59 $ 	94
Derivatives Not Designated as Hedging Instruments 	Financial Statement Line Item Impacted
Gain (Loss)
Recognized in Income
Nine Months Ended
October 2,
2026
September 26,
2025
Foreign currency contracts 	Net operating revenues 	$ 	(61) $ 	(181)
Foreign currency contracts 	Cost of goods sold 	29 	107
Foreign currency contracts 	Other income (loss) — net 	6 	154
Commodity contracts 	Cost of goods sold 	144 	(3)
Other derivative instruments 	Selling, general and administrative expenses 	29 	16
Other derivative instruments 	Other income (loss) — net 	(2) 	—
Total 	$ 	145 $ 	93
NOTE 7: SUPPLY CHAIN FINANCE PROGRAM
Our current payment terms with the majority of our suppliers are 120 days. Certain financial institutions offer a voluntary supply chain finance (“SCF”) program, which enables
our suppliers, at their sole discretion, to sell their receivables from the Company to these financial institutions on a non-recourse basis at a rate that leverages our credit rating
and thus may be more beneficial to them. The SCF program is available to suppliers of goods and services included in cost of goods sold and selling,
15

-- 18 of 66 --

general and administrative expenses in our consolidated statement of income. The Company and our suppliers agree on contractual terms for the goods and services we procure,
including prices, quantities and payment terms, regardless of whether the supplier elects to participate in the SCF program. The suppliers sell goods or services, as applicable, to
the Company and issue the associated invoices to the Company based on the agreed-upon contractual terms. Then, if they are participating in the SCF program, our suppliers
sell their invoices to the financial institutions. Our suppliers’ voluntary participation in the SCF program has no bearing on our payment terms. No guarantees are provided by
the Company or any of our subsidiaries under the SCF program. We have no economic interest in a supplier’s decision to participate in the SCF program, and we have no direct
financial relationship with the financial institutions, as it relates to the SCF program. Accordingly, amounts due to our suppliers that elected to participate in the SCF program
are included in the line item accounts payable and accrued expenses and liabilities held for sale in our consolidated balance sheet, as applicable. All activity related to amounts
due to suppliers that elected to participate in the SCF program is classified within the operating activities section of our consolidated statement of cash flows. As of October 2,
2026 and December 31, 2025, the amount of obligations outstanding that the Company has confirmed as valid to the financial institutions under the SCF program was
$1,576 million and $1,363 million, respectively. As of October 2, 2026 and December 31, 2025, these amounts included $155 million and $37 million, respectively, of
confirmed obligations outstanding related to our bottling operations in Africa that are currently held for sale. Refer to Note 2.
NOTE 8: DEBT AND BORROWING ARRANGEMENTS
Loans and notes payable consist primarily of commercial paper issued in the United States. As of December 31, 2025, we had $1,495 million in outstanding commercial paper
borrowings. We had no outstanding commercial paper borrowings as of October 2, 2026.
NOTE 9: COMMITMENTS AND CONTINGENCIES
Guarantees
As of October 2, 2026, we were contingently liable for guarantees of indebtedness owed by third parties of $807 million, of which $60 million was related to variable interest
entities. Our guarantees are primarily related to third-party customers, bottlers and vendors and have arisen through the normal course of business. These guarantees have
various terms, and none of these guarantees is individually significant. These amounts represent the maximum potential future payments that we could be required to make
under the guarantees. However, management has concluded that the likelihood of any significant amounts being paid by our Company under these guarantees is remote.
Concentrations of Credit Risk
We believe our exposure to concentrations of credit risk is limited due to the diverse geographic areas covered by our operations.
Legal Contingencies
The Company is involved in various legal proceedings. We establish reserves for specific legal proceedings when we determine that the likelihood of an unfavorable outcome is
probable and the amount of loss can be reasonably estimated. Management has also identified certain other legal matters where we believe an unfavorable outcome is
reasonably possible and/or for which no estimate of possible losses can be made. Management believes that the total liabilities of the Company that may arise as a result of
currently pending legal proceedings (excluding tax audit claims) will not have a material adverse effect on the Company taken as a whole.
Tax Audits
The Company is involved in various tax matters, with respect to some of which the outcome is uncertain. These uncertain tax matters may result in the assessment of additional
taxes.
On September 17, 2015, the Company received a Statutory Notice of Deficiency (“Notice”) from the United States Internal Revenue Service (“IRS”) seeking approximately
$3.3 billion of additional federal income tax for years 2007 through 2009. In the Notice, the IRS stated its intent to reallocate over $9 billion of income to the U.S. parent
company from certain of its foreign affiliates that the U.S. parent company licensed to manufacture, distribute, sell, market and promote its products in certain non-U.S.
markets.
The Notice concerned the Company’s transfer pricing between its U.S. parent company and certain of its foreign affiliates. IRS rules governing transfer pricing require arm’s-
length pricing of transactions between related parties such as the Company’s U.S. parent and its foreign affiliates.
To resolve the same transfer pricing issue for the tax years 1987 through 1995, the Company and the IRS had agreed in 1996 on an arm’s-length methodology for determining
the amount of U.S. taxable income that the U.S. parent company would report as compensation from its foreign licensees. The Company and the IRS memorialized this accord
in a closing agreement resolving
16

-- 19 of 66 --

that dispute (“Closing Agreement”). The Closing Agreement provided that, absent a change in material facts or circumstances or relevant federal tax law, in calculating the
Company’s income taxes going forward, the Company would not be assessed penalties by the IRS for using the agreed-upon tax calculation methodology that the Company and
the IRS agreed would be used for the 1987 through 1995 tax years.
The IRS audited and confirmed the Company’s compliance with the agreed-upon Closing Agreement methodology in five successive audit cycles for tax years 1996 through
2006.
The September 17, 2015 Notice from the IRS retroactively rejected the previously agreed-upon methodology for the 2007 through 2009 tax years in favor of an entirely
different methodology, without prior notice to the Company. Using the new tax calculation methodology, the IRS reallocated over $9 billion of income to the U.S. parent
company from its foreign licensees for tax years 2007 through 2009. Consistent with the Closing Agreement, the IRS did not assert penalties, and it has yet to do so.
The IRS designated the Company’s matter for litigation on October 15, 2015. Litigation designation is an IRS determination that forecloses to a company any and all alternative
means for resolution of a tax dispute. As a result of the IRS’ designation of the Company’s matter for litigation, the Company was forced to either accept the IRS’ newly
imposed tax assessment and pay the full amount of the asserted tax or litigate the matter in the federal courts. The matter remains subject to the IRS’ litigation designation,
preventing the Company from any attempt to settle or otherwise mutually resolve the matter with the IRS.
The Company consequently initiated litigation by filing a petition in the U.S. Tax Court (“Tax Court”) in December 2015, challenging the tax adjustments enumerated in the
Notice.
Prior to trial, the IRS increased its transfer pricing adjustment by $385 million, resulting in an additional tax adjustment of $135 million. The Company obtained a summary
judgment in its favor on a different matter related to Mexican foreign tax credits, which thereafter effectively reduced the IRS’ potential tax adjustment by $138 million.
The trial was held in the Tax Court from March through May 2018, and final post-trial briefs were filed and exchanged in April 2019.
On November 18, 2020, the Tax Court issued an opinion (“Opinion”) in which it predominantly sided with the IRS but agreed with the Company that dividends previously paid
by the foreign licensees to the U.S. parent company in reliance upon the Closing Agreement should continue to be allowed to offset royalties, including those that would
become payable to the Company in accordance with the Opinion. On November 8, 2023, the Tax Court issued a supplemental opinion (together with the original Tax Court
opinion, “Opinions”), siding with the IRS in concluding both that certain U.S. tax regulations (known as the blocked-income regulations) that address the effect of certain
Brazilian legal restrictions on royalty payments by the Company’s licensee in Brazil apply to the Company’s operations and that the Tax Court opinion in 3M Co. & Subs. v.
Commissioner (February 9, 2023) (“3M case”) controlled as to the validity of those regulations. On October 1, 2025, the U.S. Court of Appeals for the Eighth Circuit issued an
opinion reversing the judgment of the Tax Court in the 3M case. In its decision, the court concluded that the blocked-income regulation was inconsistent with Internal Revenue
Code (“IRC”) Section 482 and that the IRS therefore could not reallocate income from 3M’s subsidiary in Brazil to 3M in contravention of Brazilian restrictions on the
payment of royalties. Further, the U.S. Court of Appeals for the Eighth Circuit specifically rejected the IRS’ argument that the ability of 3M’s subsidiary in Brazil to pay
dividends, rather than royalties, meant that royalty income should not be treated as blocked. Both of these conclusions are highly supportive of the Company’s position in its
case and reinforce its prior conclusions.
The Company believes that the IRS and the Tax Court misinterpreted and misapplied the applicable regulations in reallocating income earned by the Company’s foreign
licensees to increase the Company’s U.S. tax. Moreover, the Company believes that the retroactive imposition of such tax liability using a calculation methodology different
from that previously agreed upon by the IRS and the Company, and audited by the IRS for over a decade, is unconstitutional. The Company intends to assert its claims on
appeal and vigorously defend its positions. In addition, for its litigation with the IRS and for purposes of its appeal of the Tax Court decision, the Company continues to
evaluate the implications of several significant administrative law cases recently decided by the U.S. Supreme Court, most notably Loper Bright v. Raimondo, which overruled
Chevron U.S.A., Inc. v. NRDC (“Chevron case”). Since 1984, the Chevron case had required that courts defer to agency interpretations of statutes and agency action. In Ohio v.
EPA and Garland v. Cargill, two of the recent decisions, the U.S. Supreme Court demonstrated how courts are to rule on agency interpretations and actions without the
deference previously required by the Chevron case.
On August 2, 2024, the Tax Court entered a decision reflecting additional federal income tax of $2.7 billion for the 2007 through 2009 tax years. With applicable interest, the
total liability for the 2007 through 2009 tax years resulting from the Tax Court’s decision is $6.0 billion, for which the IRS issued the Company invoices on September 3, 2024.
The Company paid those invoices (“IRS Tax Litigation Deposit”) on September 10, 2024, which stopped interest from accruing on the additional tax due for the 2007 through
2009 tax years. That amount, plus interest earned, would be refunded in full or in part if the Company’s tax positions are ultimately sustained on appeal. For the three and nine
months ended October 2, 2026, the
17

-- 20 of 66 --

Company recorded net interest income of $57 million and $155 million, respectively, related to this tax payment. For the three and nine months ended September 26, 2025, the
Company recorded net interest income of $55 million and $162 million, respectively, related to this tax payment. These amounts were recorded in the line item income taxes in
our consolidated statements of income, in accordance with our accounting policy. The payment of the IRS invoices and the related accrued interest were recorded in the line
item other noncurrent assets in our consolidated balance sheets as of October 2, 2026 and December 31, 2025. On October 22, 2024, the Company appealed the Tax Court’s
decision to the U.S. Court of Appeals for the Eleventh Circuit. The Company filed its principal appellate brief with the U.S. Court of Appeals for the Eleventh Circuit on March
12, 2025. The IRS filed its appellate brief on July 7, 2025. The Company filed its reply brief on August 27, 2025. The U.S. Court of Appeals for the Eleventh Circuit heard the
case on June 25, 2026.
In determining the amount of tax reserve to be recorded as of December 31, 2020, the Company completed the required two-step evaluation process prescribed by Accounting
Standards Codification 740, Accounting for Income Taxes. In doing so, we consulted with outside advisors, and we reviewed and considered relevant laws, rules, and
regulations, including, but not limited to, the Opinions and relevant caselaw. We also considered our intention to vigorously defend our positions and assert our various well-
founded legal claims via every available avenue of appeal. We concluded, based on the technical and legal merits of the Company’s tax positions, that it is more likely than not
the Company’s tax positions will ultimately be sustained on appeal. In addition, we considered a number of alternative transfer pricing methodologies, including the
methodology asserted by the IRS and affirmed in the Opinions (“Tax Court Methodology”), that could be applied by the courts upon final resolution of the litigation. Based on
the required probability analysis, we determined the methodologies we believe the federal courts could ultimately order to be used in calculating the Company’s tax. As a result
of this analysis, we recorded a tax reserve of $438 million during the year ended December 31, 2020 related to the application of the resulting methodologies as well as the
different tax treatment applicable to dividends originally paid to the U.S. parent company by its foreign licensees, in reliance upon the Closing Agreement, that would be
recharacterized as royalties in accordance with the Opinions and the Company’s analysis.
The Company’s conclusion that it is more likely than not the Company’s tax positions will ultimately be sustained on appeal is unchanged as of October 2, 2026. However,
based on the required probability analysis and the accrual of interest through the current reporting period, we updated our tax reserve as of October 2, 2026 to $538 million.
While the Company strongly disagrees with the IRS’ positions and the portions of the Opinions affirming such positions, it is possible that some portion or all of the
adjustments proposed by the IRS and sustained by the Tax Court could ultimately be upheld. In that event, the Company would not receive a refund of the applicable portion or
all of the $6.0 billion it paid in response to the IRS invoices issued in September 2024 and the related accrued interest receivable of $589 million as of October 2, 2026.
Additionally, the Company would likely be subject to significant additional liabilities for subsequent years, which could have a material adverse impact on the Company’s
financial position, results of operations and cash flows.
The Company calculated the potential impact of applying the Tax Court Methodology to reallocate income from foreign licensees potentially covered within the scope of the
Opinions for the 2010 through 2025 tax years, assuming such methodology were to be ultimately upheld by the courts, and the IRS were to decide to apply that methodology to
subsequent years, with consent of the federal courts. This impact would include taxes and interest accrued through December 31, 2025. The calculations incorporated the
estimated impact of correlative adjustments to the previously accrued transition tax payable under the 2017 Tax Cuts and Jobs Act. The Company estimates that the potential
aggregate remaining incremental tax and interest liability for the tax years 2010 through 2025 could be approximately $14 billion as of December 31, 2025. Additional income
tax and interest on any unpaid potential liabilities for the 2010 through 2025 tax years would continue to accrue until the time any such potential liability, or portion thereof,
were to be paid. The Company estimates the impact of the continued application of the Tax Court Methodology for the three and nine months ended October 2, 2026 would
increase the potential aggregate incremental tax and interest liability by approximately $450 million and $1.4 billion, respectively. We currently project the continued
application of the Tax Court Methodology in 2026, assuming similar facts and circumstances as of December 31, 2025 and reflecting changes enacted under the One Big
Beautiful Bill Act effective in 2026, would result in an incremental annual tax liability that would increase the Company’s effective tax rate by approximately 3.8%.
Risk Management Programs
The Company has numerous global insurance programs in place to help protect the Company from the risk of loss. In general, we are self-insured for large portions of many
different types of claims; however, we do use commercial insurance above our self-insured retentions to reduce the Company’s risk of catastrophic loss. Our reserves for the
Company’s self-insured losses are estimated using actuarial methods and assumptions of the insurance industry, adjusted for our specific expectations based on our claims
history. Our self-insurance reserves totaled $160 million and $155 million as of October 2, 2026 and December 31, 2025, respectively.
18

-- 21 of 66 --

NOTE 10: OTHER COMPREHENSIVE INCOME
AOCI attributable to shareowners of The Coca-Cola Company is separately presented in our consolidated balance sheet as a component of shareowners’ equity, which also
includes our proportionate share of equity method investees’ AOCI. OCI attributable to noncontrolling interests is allocated to, and included in, our consolidated balance sheet
as part of the line item equity attributable to noncontrolling interests.
AOCI attributable to shareowners of The Coca-Cola Company consisted of the following, net of tax (in millions):
October 2,
2026
December 31,
2025
Net foreign currency translation adjustments 	$ 	(12,949) $ 	(12,673)
Accumulated net gains (losses) on derivatives 	(36) 	(244)
Unrealized net gains (losses) on available-for-sale debt securities 	(47) 	(26)
Adjustments to pension and other postretirement benefit liabilities 	(1,058) 	(1,188)
Accumulated other comprehensive income (loss) 	$ 	(14,090) $ 	(14,131)
The following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions):
Nine Months Ended October 2, 2026
Shareowners of
The Coca-Cola Company
Noncontrolling
Interests 	Total
Consolidated net income 	$ 	12,358 $ 	102 $ 	12,460
Other comprehensive income:
Net foreign currency translation adjustments 	(276) 	(35) 	(311)
Net gains (losses) on derivatives 	208 	— 	208
Net change in unrealized gains (losses) on available-for-sale debt securities 	(21) 	— 	(21)
Net change in pension and other postretirement benefit liabilities 	130 	— 	130
Total comprehensive income (loss) 	$ 	12,399 $ 	67 $ 	12,466
Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
1
2
1
2
19

-- 22 of 66 --

The following tables present OCI attributable to shareowners of The Coca-Cola Company, including our proportionate share of equity method investees’ OCI (in millions):
Three Months Ended October 2, 2026 	Before-Tax Amount 	Income Tax After-Tax Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period 	$ 	(458) $ 	83 $ 	(375)
Gains (losses) on intra-entity transactions that are of a long-term investment nature 	(387) 	— 	(387)
Gains (losses) on net investment hedges arising during the period 	186 	(45) 	141
Net foreign currency translation adjustments 	$ 	(659) $ 	38 $ 	(621)
Derivatives:
Gains (losses) arising during the period 	$ 	52 $ 	(25) $ 	27
Reclassification adjustments recognized in net income 	65 	(15) 	50
Net gains (losses) on derivatives 	$ 	117 $ 	(40) $ 	77
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period 	$ 	(4) $ 	(4) $ 	(8)
Reclassification adjustments recognized in net income 	1 	— 	1
Net change in unrealized gains (losses) on available-for-sale debt securities 	$ 	(3) $ 	(4) $ 	(7)
Pension and other postretirement benefit liabilities:
Net pension and other postretirement benefit liabilities arising during the period 	$ 	(83) $ 	8 $ 	(75)
Reclassification adjustments recognized in net income 	188 	(26) 	162
Net change in pension and other postretirement benefit liabilities 	$ 	105 $ 	(18) $ 	87
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company 	$ 	(440) $ 	(24) $ 	(464)
Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
Nine Months Ended October 2, 2026 	Before-Tax Amount 	Income Tax After-Tax Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period 	$ 	264 $ 	74 $ 	338
Gains (losses) on intra-entity transactions that are of a long-term investment nature 	(1,048) 	— 	(1,048)
Gains (losses) on net investment hedges arising during the period 	572 	(138) 	434
Net foreign currency translation adjustments 	$ 	(212) $ 	(64) $ 	(276)
Derivatives:
Gains (losses) arising during the period 	$ 	107 $ 	(38) $ 	69
Reclassification adjustments recognized in net income 	183 	(44) 	139
Net gains (losses) on derivatives 	$ 	290 $ 	(82) $ 	208
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period 	$ 	(24) $ 	1 $ 	(23)
Reclassification adjustments recognized in net income 	2 	— 	2
Net change in unrealized gains (losses) on available-for-sale debt securities 	$ 	(22) $ 	1 $ 	(21)
Pension and other postretirement benefit liabilities:
Net pension and other postretirement benefit liabilities arising during the period 	$ 	(70) $ 	5 $ 	(65)
Reclassification adjustments recognized in net income 	231 	(36) 	195
Net change in pension and other postretirement benefit liabilities 	$ 	161 $ 	(31) $ 	130
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company 	$ 	217 $ 	(176) $ 	41
Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
1
1
2
1
2
1
1
2
1
2
20

-- 23 of 66 --

Three Months Ended September 26, 2025 	Before-Tax Amount 	Income Tax After-Tax Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period 	$ 	482 $ 	(96) $ 	386
Reclassification adjustments recognized in net income 	38 	— 	38
Gains (losses) on intra-entity transactions that are of a long-term investment nature 	(39) 	— 	(39)
Gains (losses) on net investment hedges arising during the period 	35 	(8) 	27
Reclassification to noncontrolling interests 	226 	— 	226
Net foreign currency translation adjustments 	$ 	742 $ 	(104) $ 	638
Derivatives:
Gains (losses) arising during the period 	$ 	80 $ 	(12) $ 	68
Reclassification adjustments recognized in net income 	112 	(28) 	84
Net gains (losses) on derivatives 	$ 	192 $ 	(40) $ 	152
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period 	$ 	12 $ 	(4) $ 	8
Reclassification adjustments recognized in net income 	1 	— 	1
Net change in unrealized gains (losses) on available-for-sale debt securities 	$ 	13 $ 	(4) $ 	9
Pension and other postretirement benefit liabilities:
Net pension and other postretirement benefit liabilities arising during the period 	$ 	(10) $ 	(1) $ 	(11)
Reclassification adjustments recognized in net income 	24 	(6) 	18
Net change in pension and other postretirement benefit liabilities 	$ 	14 $ 	(7) $ 	7
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company 	$ 	961 $ 	(155) $ 	806
Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
Refer to Note 11 for additional information related to the noncontrolling interest in our bottling operations in India.
Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
1
2
1
3
1
2
3
21

-- 24 of 66 --

Nine Months Ended September 26, 2025 	Before-Tax Amount 	Income Tax After-Tax Amount
Foreign currency translation adjustments:
Translation adjustments arising during the period 	$ 	585 $ 	(189) $ 	396
Reclassification adjustments recognized in net income 	72 	(2) 	70
Gains (losses) on intra-entity transactions that are of a long-term investment nature 	2,872 	— 	2,872
Gains (losses) on net investment hedges arising during the period 	(1,710) 	427 	(1,283)
Reclassification to noncontrolling interests 	226 	— 	226
Net foreign currency translation adjustments 	$ 	2,045 $ 	236 $ 	2,281
Derivatives:
Gains (losses) arising during the period 	$ 	(679) $ 	175 $ 	(504)
Reclassification adjustments recognized in net income 	73 	(18) 	55
Net gains (losses) on derivatives 	$ 	(606) $ 	157 $ 	(449)
Available-for-sale debt securities:
Unrealized gains (losses) arising during the period 	$ 	44 $ 	(14) $ 	30
Reclassification adjustments recognized in net income 	2 	— 	2
Net change in unrealized gains (losses) on available-for-sale debt securities 	$ 	46 $ 	(14) $ 	32
Pension and other postretirement benefit liabilities:
Net pension and other postretirement benefit liabilities arising during the period 	$ 	(49) $ 	13 $ 	(36)
Reclassification adjustments recognized in net income 	83 	(20) 	63
Net change in pension and other postretirement benefit liabilities 	$ 	34 $ 	(7) $ 	27
Other comprehensive income (loss) attributable to shareowners of The Coca-Cola
Company 	$ 	1,519 $ 	372 $ 	1,891
Refer to Note 6 for additional information related to the net gains or losses on derivative instruments.
Refer to Note 11 for additional information related to the noncontrolling interest in our bottling operations in India.
Refer to Note 4 for additional information related to the net unrealized gains or losses on available-for-sale debt securities.
1
2
1
3
1
2
3
22

-- 25 of 66 --

The following table presents the amounts and line items in our consolidated statements of income where adjustments reclassified from AOCI into income were recorded
(in millions):
Amount Reclassified from AOCI
into Income
Description of AOCI Component 	Financial Statement Line Item Impacted
Three Months Ended October
2, 2026
Nine Months Ended October 2,
2026
Derivatives:
Foreign currency contracts 	Net operating revenues 	$ 	65 	$ 	199
Foreign currency and commodity contracts 	Cost of goods sold 	(11) 	(46)
Foreign currency and interest rate contracts 	Interest expense 	1 	5
Foreign currency contracts 	Other income (loss) — net 	10 	25
Income before income taxes 	65 	183
Income taxes 	(15) 	(44)
Consolidated net income 	$ 	50 	$ 	139
Available-for-sale debt securities:
Sale of debt securities 	Other income (loss) — net 	$ 	1 	$ 	2
Income before income taxes 	1 	2
Income taxes 	— 	—
Consolidated net income 	$ 	1 	$ 	2
Pension and other postretirement benefit liabilities:
Settlement loss (gain) 	Other income (loss) — net 	$ 	167 	$ 	167
Amortization of net actuarial loss (gain) 	Other income (loss) — net 	21 	64
Income before income taxes 	188 	231
Income taxes 	(26) 	(36)
Consolidated net income 	$ 	162 	$ 	195
Related to the purchase of a buy-out annuity contract (“buy-out”) for a non-U.S. defined benefit plan. Refer to Note 13.
NOTE 11: CHANGES IN EQUITY
The following tables provide a reconciliation of the beginning and ending carrying amounts of total equity, equity attributable to shareowners of The Coca-Cola Company and
equity attributable to noncontrolling interests (in millions):
Shareowners of The Coca-Cola Company
Three Months Ended October 2, 2026
Common Shares
Outstanding 	Total
Reinvested
Earnings
Accumulated Other
Comprehensive
Income (Loss) Common Stock Capital Surplus 	Treasury Stock
Non-controlling
Interests
July 3, 2026 	4,303 $ 	38,315 $ 	84,169 $ 	(13,626) $ 	1,760 $ 	20,741 $ 	(56,894) $ 	2,165
Comprehensive income (loss) 	— 	3,545 	4,009 	(464) 	— 	— 	— 	—
Dividends paid/payable to shareowners of The
Coca-Cola Company ($0.53 per share) 	— 	(2,280) 	(2,280) 	— 	— 	— 	— 	—
Dividends paid to noncontrolling
interests 	— 	(4) 	— 	— 	— 	— 	— 	(4)
Purchases of treasury stock 	(3) 	(238) 	— 	— 	— 	— 	(238) 	—
Impact related to stock-based compensation plans 	2 	195 	— 	— 	— 	153 	42 	—
October 2, 2026 	4,302 $ 	39,533 $ 	85,898 $ 	(14,090) $ 	1,760 $ 	20,894 $ 	(57,090) $ 	2,161
1
1
23

-- 26 of 66 --

Shareowners of The Coca-Cola Company
Nine Months Ended October 2, 2026
Common Shares
Outstanding 	Total
Reinvested
Earnings
Accumulated Other
Comprehensive
Income (Loss) Common Stock Capital Surplus 	Treasury Stock
Non-controlling
Interests
December 31, 2025 	4,302 $ 	34,275 $ 	80,382 $ 	(14,131) $ 	1,760 $ 	20,581 $ 	(56,423) $ 	2,106
Comprehensive income (loss) 	— 	12,466 	12,358 	41 	— 	— 	— 	67
Dividends paid/payable to shareowners of The
Coca-Cola Company ($1.59 per share) 	— 	(6,842) 	(6,842) 	— 	— 	— 	— 	—
Dividends paid to noncontrolling interests 	— 	(12) 	— 	— 	— 	— 	— 	(12)
Purchases of treasury stock 	(10) 	(787) 	— 	— 	— 	— 	(787) 	—
Impact related to stock-based compensation plans 	10 	433 	— 	— 	— 	313 	120 	—
October 2, 2026 	4,302 $ 	39,533 $ 	85,898 $ 	(14,090) $ 	1,760 $ 	20,894 $ 	(57,090) $ 	2,161
Shareowners of The Coca-Cola Company
Three Months Ended September 26, 2025
Common Shares
Outstanding 	Total
Reinvested
Earnings
Accumulated Other
Comprehensive
Income (Loss) Common Stock Capital Surplus 	Treasury Stock
Non-controlling
Interests
June 27, 2025 	4,304 $ 	30,182 $ 	78,803 $ 	(15,758) $ 	1,760 $ 	19,970 $ 	(56,190) $ 	1,597
Comprehensive income (loss) 	— 	4,288 	3,696 	806 	— 	— 	— 	(214)
Dividends paid/payable to shareowners of The
Coca-Cola Company ($0.51 per share) 	— 	(2,194) 	(2,194) 	— 	— 	— 	— 	—
Dividends paid to noncontrolling interests 	— 	(7) 	— 	— 	— 	— 	— 	(7)
Purchases of treasury stock 	(3) 	(174) 	— 	— 	— 	— 	(174) 	—
Impact related to stock-based compensation plans 	1 	92 	— 	— 	— 	83 	9 	—
Sale of subsidiary shares 	— 	1,080 	— 	— 	— 	436 	— 	644
September 26, 2025 	4,302 $ 	33,267 $ 	80,305 $ 	(14,952) $ 	1,760 $ 	20,489 $ 	(56,355) $ 	2,020
In July 2025, we sold a 40% noncontrolling interest in our bottling operations in India to a local partner for approximately $1.3 billion, which, net of direct costs, resulted in an increase to total
equity of $1.1 billion. As a result, 40% of the subsidiary’s equity was allocated to the noncontrolling interest and the remaining amount was recorded in capital surplus. Additionally, $226 million
of foreign currency translation adjustments included in AOCI were allocated to the noncontrolling interest.
1
1
1
24

-- 27 of 66 --

Shareowners of The Coca-Cola Company
Nine Months Ended September 26, 2025
Common Shares
Outstanding 	Total
Reinvested
Earnings
Accumulated Other
Comprehensive
Income (Loss) Common Stock Capital Surplus 	Treasury Stock
Non-controlling
Interests
December 31, 2024 	4,302 $ 	26,372 $ 	76,054 $ 	(16,843) $ 	1,760 $ 	19,801 $ 	(55,916) $ 	1,516
Comprehensive income (loss) 	— 	12,590 	10,836 	1,891 	— 	— 	— 	(137)
Dividends paid/payable to shareowners of The
Coca-Cola Company ($1.53 per share) 	— 	(6,585) 	(6,585) 	— 	— 	— 	— 	—
Dividends paid to noncontrolling interests 	— 	(16) 	— 	— 	— 	— 	— 	(16)
Contributions by noncontrolling interests 	— 	13 	— 	— 	— 	— 	— 	13
Purchases of treasury stock 	(8) 	(534) 	— 	— 	— 	— 	(534) 	—
Impact related to stock-based compensation plans 	8 	347 	— 	— 	— 	252 	95 	—
Sale of subsidiary shares 	— 	1,080 	— 	— 	— 	436 	— 	644
September 26, 2025 	4,302 $ 	33,267 $ 	80,305 $ 	(14,952) $ 	1,760 $ 	20,489 $ 	(56,355) $ 	2,020
In July 2025, we sold a 40% noncontrolling interest in our bottling operations in India to a local partner for approximately $1.3 billion, which, net of direct costs, resulted in an increase to total
equity of $1.1 billion. As a result, 40% of the subsidiary’s equity was allocated to the noncontrolling interest and the remaining amount was recorded in capital surplus. Additionally, $226 million
of foreign currency translation adjustments included in AOCI were allocated to the noncontrolling interest.
NOTE 12: SIGNIFICANT OPERATING AND NONOPERATING ITEMS
Other Operating Charges
During the three months ended October 2, 2026, the Company recorded other operating charges of $10 million. These charges consisted of $6 million related to North America
modernization initiatives and $4 million for the amortization of noncompete agreements related to the BA Sports Nutrition, LLC (“BodyArmor”) acquisition in 2021.
During the nine months ended October 2, 2026, the Company recorded other operating charges of $54 million. These charges consisted of $19 million related to an
indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $16 million related to North America modernization initiatives,
$11 million for the amortization of noncompete agreements related to the BodyArmor acquisition and $8 million related to tax litigation expense.
During the three months ended September 26, 2025, the Company recorded other operating charges of $58 million. These charges included $27 million related to an
indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $24 million related to the Company’s productivity and reinvestment
program, $4 million for the amortization of noncompete agreements related to the BodyArmor acquisition and $3 million related to tax litigation expense.
During the nine months ended September 26, 2025, the Company recorded other operating charges of $202 million. These charges consisted of $47 million related to the
remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife, LLC (“fairlife”) in 2020, which brought the total liability to
$6,173 million and was paid in March 2025. Additionally, other operating charges included $63 million related to the Company’s productivity and reinvestment program,
$35 million related to an indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $31 million related to the impairment of a
trademark that impacted the Latin America operating segment, $11 million for the amortization of noncompete agreements related to the BodyArmor acquisition, $8 million
related to tax litigation expense and $7 million of transaction costs related to the refranchising of our bottling operations in certain territories in India.
Refer to Note 2 for additional information on our divestiture activities. Refer to Note 9 for additional information on the tax litigation. Refer to Note 15 for additional
information on the impairment charge.
Other Nonoperating Items
Equity Income (Loss) — Net
During the three and nine months ended October 2, 2026, the Company recorded net charges of $8 million and $30 million, respectively. During the three and nine months
ended September 26, 2025, the Company recorded a net gain of $7 million and a net charge of $21 million, respectively. These amounts represent the Company’s proportionate
share of significant operating and nonoperating items recorded by certain of our equity method investees.
1
1
1
25

-- 28 of 66 --

Other Income (Loss) — Net
During the three months ended October 2, 2026, the Company recognized a net gain of $37 million related to realized and unrealized gains and losses on equity securities and
trading debt securities as well as realized gains and losses on available-for-sale debt securities. Additionally, the Company recorded charges of $167 million and $25 million for
a settlement loss and special termination benefits, respectively, related to a non-U.S. pension plan. The Company also recorded a reduction in the previously recorded
impairment charge of $5 million related to our bottling operations in Africa, which are held for sale. This reduction is based on management’s revised estimates.
During the nine months ended October 2, 2026, the Company recognized a net gain of $338 million related to realized and unrealized gains and losses on equity securities and
trading debt securities as well as realized gains and losses on available-for-sale debt securities. Additionally, the Company recorded charges of $167 million and $25 million for
a settlement loss and special termination benefits, respectively, related to a non-U.S. pension plan. The Company also recorded a reduction in the previously recorded
impairment charge of $61 million related to our bottling operations in Africa, which are held for sale. This reduction is based on management’s revised estimates.
During the three months ended September 26, 2025, the Company recognized a net gain of $151 million related to realized and unrealized gains and losses on equity securities
and trading debt securities as well as realized gains and losses on available-for-sale debt securities, a charge of $393 million related to certain operations held for sale in Nigeria
and a charge of $8 million related to the refranchising of certain bottling operations in Ghana.
During the nine months ended September 26, 2025, the Company recognized a gain of $331 million related to the sale of a portion of our ownership interest in CCEP, a net gain
of $295 million related to realized and unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt
securities and a gain of $102 million related to the refranchising of our bottling operations in certain territories in India. The Company also recorded a charge of $393 million
related to certain operations held for sale in Nigeria and recorded other-than-temporary impairment charges of $40 million related to an equity method investee in Latin
America and $25 million related to a joint venture in Latin America. Additionally, the Company recorded a charge of $36 million related to the refranchising of certain bottling
operations in Ghana, and charges of $25 million and $11 million for special termination benefits and a curtailment loss, respectively, related to non-U.S. pension activity.
Refer to Note 2 for additional information on our bottling operations in Africa and our divestiture activities. Refer to Note 4 for additional information on equity and debt
securities. Refer to Note 13 for additional information on our pension activities. Refer to Note 15 for additional information on the impairment charges and the bottling
operations in Ghana.
NOTE 13: PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
Net periodic benefit cost or income for our pension and other postretirement benefit plans consisted of the following (in millions):
Pension Plans
Other Postretirement
Benefit Plans
Three Months Ended
October 2,
2026
September 26,
2025
October 2,
2026
September 26,
2025
Service cost 	$ 	26 $ 	26 	$ 	1 $ 	1
Interest cost 	74 	76 	2 	3
Expected return on plan assets 	(94) 	(106) 	(1) 	(1)
Amortization of prior service cost (credit) 	1 	1 	(1) 	(1)
Amortization of net actuarial loss (gain) 	21 	25 	— 	(1)
Settlement loss (gain) 	167 	— 	— 	—
Special termination benefits 	25 	— 	— 	—
Net periodic benefit cost (income) 	$ 	220 $ 	22 	$ 	1 $ 	1
The weighted-average expected long-term rates of return on plan assets used in computing 2026 net periodic benefit cost (income) were 6.25% for pension plans and 6.75% for other
postretirement benefit plans.
The settlement loss is related to the buy-out of a non-U.S. defined benefit plan.
The special termination benefits represent benefit uplifts provided to plan participants included in the buy-out.
1
2
3
1
2
3
26

-- 29 of 66 --

Pension Plans
Other Postretirement
Benefit Plans
Nine Months Ended
October 2,
2026
September 26,
2025
October 2,
2026
September 26,
2025
Service cost 	$ 	78 $ 	77 	$ 	2 $ 	3
Interest cost 	225 	225 	7 	8
Expected return on plan assets 	(289) 	(314) 	(3) 	(3)
Amortization of prior service cost (credit) 	2 	1 	(2) 	(2)
Amortization of net actuarial loss (gain) 	64 	76 	— 	(1)
Settlement loss (gain) 	167 	— 	— 	—
Curtailment loss (gain) 	— 	11 	— 	—
Special termination benefits 	25 	25 	— 	—
Net periodic benefit cost (income) 	$ 	272 $ 	101 	$ 	4 $ 	5
The weighted-average expected long-term rates of return on plan assets used in computing 2026 net periodic benefit cost (income) were 6.25% for pension plans and 6.75% for other
postretirement benefit plans.
The settlement loss is related to the buy-out of a non-U.S. defined benefit plan.
The curtailment loss was primarily related to the buy-in annuity purchase (“buy-in”) for a non-U.S. defined benefit plan. The Company intends to convert the buy-in to a buy-out in the future, at
which time the insurer would assume full responsibility for the plan obligations.
The special termination benefits represent benefit uplifts provided to plan participants included in the 2026 buy-out and the 2025 buy-in.
All of the amounts in the tables above, other than service cost, were recorded in the line item other income (loss) — net in our consolidated statements of income. During the
nine months ended October 2, 2026, the Company contributed $18 million to our pension trusts, offset by a $218 million transfer of surplus non-U.S. plan assets from pension
trusts to general assets of the Company. We anticipate making additional contributions of approximately $9 million during the remainder of 2026. The Company contributed
$23 million to our pension trusts, offset by a $331 million transfer of surplus non-U.S. plan assets from pension trusts to general assets of the Company during the nine months
ended September 26, 2025.
NOTE 14: INCOME TAXES
The Company recorded income taxes of $777 million (16.1% effective tax rate) and $500 million (11.9% effective tax rate) during the three months ended October 2, 2026 and
September 26, 2025, respectively. The Company recorded income taxes of $2,459 million (16.5% effective tax rate) and $2,215 million (17.0% effective tax rate) during the
nine months ended October 2, 2026 and September 26, 2025, respectively.
The Company’s effective tax rates for the three and nine months ended October 2, 2026 and September 26, 2025 vary from the statutory U.S. federal tax rate of 21.0%,
primarily due to the tax impact of significant operating and nonoperating items, as described in Note 12, along with the tax benefits of having significant earnings generated
outside of the United States and significant earnings generated in investments accounted for under the equity method, both of which are generally taxed at rates lower than the
statutory U.S. federal tax rate.
The Company’s effective tax rates for the three and nine months ended October 2, 2026 included $172 million and $491 million, respectively, of net tax benefits related to
various discrete tax items, including net interest income of $57 million and $155 million, respectively, related to the IRS Tax Litigation Deposit recorded in the line item
income taxes in our consolidated statements of income, in accordance with our accounting policy. The Company’s effective tax rates for the three and nine months ended
October 2, 2026 also included net tax benefits of $117 million and $298 million, respectively, primarily related to return to provision adjustments.
The Company’s effective tax rates for the three and nine months ended September 26, 2025 included $442 million and $597 million, respectively, of net tax benefits related to
various discrete tax items, including net interest income of $55 million and $162 million, respectively, related to the IRS Tax Litigation Deposit recorded in the line item
income taxes in our consolidated statements of income, in accordance with our accounting policy. Also included were tax benefits of $258 million and $344 million,
respectively, related to changes in the Company’s indefinite reinvestment assertion and reassessments of the realizability of deferred tax assets for certain foreign entities.
During the nine months ended October 2, 2026, the Company invested $75 million in limited partnerships that receive tax credits and other tax benefits by constructing, owning
and operating alternative energy generation facilities. During the three and nine months ended October 2, 2026, the Company received tax credits and other income tax benefits
of $193 million and $198 million, respectively, and recognized amortization expense of $176 million and $180 million, respectively, related to all of
1
2
3
4
1
2
3
4
27

-- 30 of 66 --

our investments of this nature. The amount of non-income tax-related activity and other returns related to these investments was not material during the three and nine months
ended October 2, 2026.
During the nine months ended September 26, 2025, the Company invested $271 million in limited partnerships that receive tax credits and other tax benefits by constructing,
owning and operating alternative energy generation facilities. During the three and nine months ended September 26, 2025, the Company received tax credits and other income
tax benefits of $13 million and $168 million, respectively, and recognized amortization expense of $11 million and $153 million, respectively, related to all of our investments
of this nature. The amount of non-income tax-related activity and other returns related to these investments was not material during the three and nine months ended
September 26, 2025.
As of October 2, 2026 and December 31, 2025, the carrying values of these investments were $70 million and $32 million, respectively. The Company recorded $174 million
and $32 million of unfunded commitments related to these investments in the line item accounts payable and accrued expenses in our consolidated balance sheets as of
October 2, 2026 and December 31, 2025, respectively.
We are currently in litigation with the IRS for tax years 2007 through 2009. Refer to Note 9.
NOTE 15: FAIR VALUE MEASUREMENTS
Recurring Fair Value Measurements
The following tables summarize assets and liabilities measured at fair value on a recurring basis (in millions):
October 2, 2026 	Level 1 	Level 2 	Level 3 	Other
Netting
Adjustment
Fair Value
Measurements
Assets:
Equity securities with readily determinable values 	$ 	2,208 $ 	535 $ 	92 	$ 	395 $ 	— 	$ 	3,230
Debt securities 	— 	2,718 	— 	— 	— 	2,718
Derivatives 	— 	767 	— 	— 	(596) 	171
Total assets 	$ 	2,208 $ 	4,020 $ 	92 	$ 	395 $ 	(596) 	$ 	6,119
Liabilities:
Derivatives 	$ 	2 $ 	1,186 $ 	— 	$ 	— $ 	(1,171) 	$ 	17
Total liabilities 	$ 	2 $ 	1,186 $ 	— 	$ 	— $ 	(1,171) 	$ 	17
Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt securities.
Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included
to reconcile to the amounts presented in Note 4.
Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with
the same counterparties. There were no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting
requirements. Refer to Note 6.
The Company is obligated to return $90 million in cash collateral it has netted against its derivative position.
The Company has the right to reclaim $657 million in cash collateral it has netted against its derivative position.
The Company’s derivative financial instruments were recorded at fair value in our consolidated balance sheet as follows: $11 million in the line item assets held for sale, $160 million in the line
item other noncurrent assets, $2 million in the line item liabilities held for sale and $15 million in the line item other noncurrent liabilities. Refer to Note 6 for additional information related to the
composition of our derivatives portfolio.
3 	4
1
1
2 	5 	7
2 	6 	7
1
2
3
4
5
6
7
28

-- 31 of 66 --

December 31, 2025 	Level 1 	Level 2 	Level 3 	Other
Netting
Adjustment
Fair Value
Measurements
Assets:
Equity securities with readily determinable values 	$ 	2,148 $ 	237 $ 	61 	$ 	143 $ 	— 	$ 	2,589
Debt securities 	— 	1,824 	— 	— 	— 	1,824
Derivatives 	— 	441 	— 	— 	(403) 	38
Total assets 	$ 	2,148 $ 	2,502 $ 	61 	$ 	143 $ 	(403) 	$ 	4,451
Liabilities:
Derivatives 	$ 	9 $ 	1,040 $ 	— 	$ 	— $ 	(954) 	$ 	95
Total liabilities 	$ 	9 $ 	1,040 $ 	— 	$ 	— $ 	(954) 	$ 	95
Refer to Note 4 for additional information related to the composition of our equity securities with readily determinable values and debt securities.
Refer to Note 6 for additional information related to the composition of our derivatives portfolio.
Certain investments that are measured at fair value using the net asset value per share (or its equivalent) practical expedient have not been categorized in the fair value hierarchy but are included
to reconcile to the amounts presented in Note 4.
Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with
the same counterparties. There were no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting
requirements. Refer to Note 6.
The Company was obligated to return $48 million in cash collateral it had netted against its derivative position.
The Company had the right to reclaim $597 million in cash collateral it had netted against its derivative position.
The Company’s derivative financial instruments were recorded at fair value in our consolidated balance sheet as follows: $3 million in the line item assets held for sale, $35 million in the line
item other noncurrent assets, $5 million in the line item liabilities held for sale and $90 million in the line item other noncurrent liabilities. Refer to Note 6 for additional information related to the
composition of our derivatives portfolio.
Excluding the remeasurement of the fairlife contingent consideration liability during the nine months ended September 26, 2025, gross realized and unrealized gains and losses
on Level 3 assets and liabilities were not significant for the three and nine months ended October 2, 2026 and September 26, 2025. Refer to Note 12 for additional information
on the fairlife contingent consideration liability.
The Company recognizes transfers between levels within the hierarchy as of the beginning of the reporting period. Gross transfers between levels within the hierarchy were not
significant for the three and nine months ended October 2, 2026 and September 26, 2025.
Nonrecurring Fair Value Measurements
The gains and losses on assets measured at fair value on a nonrecurring basis are summarized in the following table (in millions):
Gains (Losses)
Three Months Ended 	Nine Months Ended
October 2,
2026 September 26,
2025 October 2,
2026 September 26,
2025
Assets held for sale 	$ 	5 	$ 	(235) 	$ 	61 	$ 	(263)
Other-than-temporary impairment charges 	— 	— 	— 	(65)
Impairment of intangible assets 	— 	— 	— 	(31)
Total 	$ 	5 	$ 	(235) 	$ 	61 	$ 	(359)
During the three and nine months ended October 2, 2026, the Company recorded reductions in the previously recorded impairment charge related to our bottling operations in Africa, which are
held for sale, of $5 million and $61 million, respectively, based on Level 3 inputs. These reductions were recorded in the line item other income (loss) — net in our consolidated statements of
income. Refer to Note 2.
The Company is required to record assets and liabilities that are held for sale at the lower of carrying value or fair value less any costs to sell based on the agreed-upon sale price. During the three
and nine months ended September 26, 2025, the Company recorded a charge of $235 million in the line item other income (loss) — net in our consolidated statements of income. This charge was
due to the write-off of assets related to the sale of certain finished product operations in Nigeria and was calculated based on Level 3 inputs. Additionally, during the nine months ended
September 26, 2025, the Company recorded a charge of $28 million in the line item other income (loss) — net in our consolidated statement of income. This charge was due to the write-down of
assets held for sale related to the refranchising of certain bottling operations in Ghana. This charge, which was calculated based on Level 3 inputs, primarily related to property, plant and
equipment. These operations were sold in July 2025, resulting in an additional loss of $8 million.
3 	4
1
1
2 	5 	7
2 	6 	7
1
2
3
4
5
6
7
1 	2 	1 	2
3,4
5
1
2
29

-- 32 of 66 --

During the nine months ended September 26, 2025, the Company recorded an other-than-temporary impairment charge of $40 million related to an equity method investee in Latin America. This
impairment charge was derived using Level 3 inputs and was primarily driven by revised projections of future operating results. This charge was recorded in the line item other income (loss) —
net in our consolidated statement of income.
During the nine months ended September 26, 2025, the Company recorded an other-than-temporary impairment charge of $25 million related to a joint venture in Latin America. This impairment
charge was derived using Level 3 inputs and was due to the joint venture’s restructuring and planned liquidation. This charge was recorded in the line item other income (loss) — net in our
consolidated statement of income.
During the nine months ended September 26, 2025, the Company recorded an asset impairment charge of $31 million related to a trademark in Latin America. This impairment charge was
derived using Level 3 inputs and was primarily driven by revised projections of future operating results and changes in macroeconomic conditions. This charge was recorded in the line item other
operating charges in our consolidated statement of income. The remaining carrying value of the trademark is $55 million.
Other Fair Value Disclosures
The carrying values of cash and cash equivalents, short-term investments, trade accounts receivable, accounts payable and accrued expenses, and loans and notes payable
approximate their fair values because of the relatively short-term maturities of these financial instruments. The fair value of our long-term debt is estimated using Level 2 inputs
based on quoted prices for those instruments. Where quoted prices are not available, the fair value is estimated using discounted cash flows and market-based expectations for
interest rates, credit risk and the contractual terms of the debt instruments. As of October 2, 2026, the carrying value and fair value of our long-term debt, including the current
portion, were $41,546 million and $35,398 million, respectively. As of December 31, 2025, the carrying value and fair value of our long-term debt, including the current
portion, were $43,941 million and $39,385 million, respectively.
3
4
5
30

-- 33 of 66 --

NOTE 16: OPERATING SEGMENTS
Our organizational structure consists of the following five operating segments: Europe, Middle East and Africa (“EMEA”), Latin America, North America, Asia Pacific, and
Bottling Investments. Information about our Company’s operations by operating segment and Corporate is as follows (in millions):
EMEA
Latin
America
North
America 	Asia Pacific
Bottling
Investments
Operating
Segments Total 	Corporate 	Eliminations 	Consolidated
Three Months Ended October 2, 2026
Net operating revenues:
Third party 	$ 	2,982 $ 	1,958 $ 	5,384 $ 	1,498 $ 	1,520 $ 	13,342 $ 	38 $ 	— $ 	13,380
Intersegment 	122 	— 	2 	65 	3 	192 	— 	(192) 	—
Total net operating revenues 	3,104 	1,958 	5,386 	1,563 	1,523 	13,534 	38 	(192) 	13,380
Cost of goods sold 	768 	293 	2,565 	497 	1,038 	5,161 	(39) 	(192) 	4,930
Selling, general and administrative expenses 	1,165 	513 	1,049 	503 	280 	3,510 	465 	— 	3,975
Other operating charges 	— 	— 	6 	— 	— 	6 	4 	— 	10
Operating income (loss) 	$ 	1,171 $ 	1,152 $ 	1,766 $ 	563 $ 	205 $ 	4,857 $ 	(392) $ 	— $ 	4,465
Interest income 	224
Interest expense 	354
Equity income (loss) — net 	653
Other income (loss) — net 	(155)
Income before income taxes 	$ 	4,833
Other segment information:
Capital expenditures 	$ 	50 $ 	— $ 	135 $ 	— $ 	90 $ 	275 $ 	104 $ 	— $ 	379
Depreciation and amortization 	45 	9 	91 	14 	85 	244 	9 	— 	253
Three Months Ended September 26, 2025
Net operating revenues:
Third party 	$ 	2,818 $ 	1,572 $ 	5,249 $ 	1,438 $ 	1,344 $ 	12,421 $ 	34 $ 	— $ 	12,455
Intersegment 	178 	1 	4 	68 	2 	253 	— 	(253) 	—
Total net operating revenues 	2,996 	1,573 	5,253 	1,506 	1,346 	12,674 	34 	(253) 	12,455
Cost of goods sold 	867 	281 	2,523 	471 	955 	5,097 	(47) 	(253) 	4,797
Selling, general and administrative expenses 	1,032 	395 	1,049 	514 	334 	3,324 	294 	— 	3,618
Other operating charges 	— 	— 	— 	— 	— 	— 	58 	— 	58
Operating income (loss) 	$ 	1,097 $ 	897 $ 	1,681 $ 	521 $ 	57 $ 	4,253 $ 	(271) $ 	— $ 	3,982
Interest income 	185
Interest expense 	391
Equity income (loss) — net 	644
Other income (loss) — net 	(237)
Income before income taxes 	$ 	4,183
Other segment information:
Capital expenditures 	$ 	66 $ 	— $ 	176 $ 	12 $ 	105 $ 	359 $ 	120 $ 	— $ 	479
Depreciation and amortization 	40 	8 	83 	12 	78 	221 	47 	— 	268
31

-- 34 of 66 --

EMEA
Latin
America
North
America 	Asia Pacific
Bottling
Investments
Operating
Segments Total 	Corporate 	Eliminations 	Consolidated
Nine Months Ended October 2, 2026
Net operating revenues:
Third party 	$ 	8,876 $ 	5,475 $ 	15,680 $ 	4,411 $ 	4,683 $ 	39,125 $ 	107 $ 	— $ 	39,232
Intersegment 	480 	— 	7 	241 	7 	735 	— 	(735) 	—
Total net operating revenues 	9,356 	5,475 	15,687 	4,652 	4,690 	39,860 	107 	(735) 	39,232
Cost of goods sold 	2,345 	842 	7,556 	1,484 	3,216 	15,443 	(193) 	(735) 	14,515
Selling, general and administrative expenses 	3,272 	1,266 	3,048 	1,413 	987 	9,986 	1,181 	— 	11,167
Other operating charges 	— 	— 	16 	— 	— 	16 	38 	— 	54
Operating income (loss) 	$ 	3,739 $ 	3,367 $ 	5,067 $ 	1,755 $ 	487 $ 	14,415 $ 	(919) $ 	— $ 	13,496
Interest income 	644
Interest expense 	1,098
Equity income (loss) — net 	1,641
Other income (loss) — net 	236
Income before income taxes 	$ 	14,919
Other segment information:
Capital expenditures 	$ 	150 $ 	— $ 	397 $ 	1 $ 	255 $ 	803 $ 	260 $ 	— $ 	1,063
Depreciation and amortization 	144 	26 	282 	37 	254 	743 	40 	— 	783
Nine Months Ended September 26, 2025
Net operating revenues:
Third party 	$ 	8,307 $ 	4,636 $ 	14,636 $ 	4,227 $ 	4,214 $ 	36,020 $ 	99 $ 	— $ 	36,119
Intersegment 	522 	1 	7 	272 	6 	808 	— 	(808) 	—
Total net operating revenues 	8,829 	4,637 	14,643 	4,499 	4,220 	36,828 	99 	(808) 	36,119
Cost of goods sold 	2,521 	818 	7,034 	1,337 	2,983 	14,693 	(211) 	(808) 	13,674
Selling, general and administrative expenses 	2,821 	1,030 	2,966 	1,370 	1,002 	9,189 	1,133 	— 	10,322
Other operating charges 	— 	31 	— 	— 	— 	31 	171 	— 	202
Operating income (loss) 	$ 	3,487 $ 	2,758 $ 	4,643 $ 	1,792 $ 	235 $ 	12,915 $ 	(994) $ 	— $ 	11,921
Interest income 	553
Interest expense 	1,223
Equity income (loss) — net 	1,556
Other income (loss) — net 	229
Income before income taxes 	$ 	13,036
Other segment information:
Capital expenditures 	$ 	156 $ 	1 $ 	445 $ 	17 $ 	329 $ 	948 $ 	282 $ 	— $ 	1,230
Depreciation and amortization 	139 	23 	245 	34 	230 	671 	143 	— 	814
Effective March 31, 2026, our Company’s chief operating decision maker (“CODM”) is our Chief Executive Officer. Information about total assets by segment is not disclosed
because such information is not regularly provided to, or used by, our CODM.
During the three and nine months ended October 2, 2026 and September 26, 2025, our operating segments and Corporate were impacted by acquisition and divestiture
activities. Refer to Note 2. Additionally, during the three and nine months ended October 2, 2026 and September 26, 2025, our operating segments and Corporate were
impacted by certain significant operating and nonoperating items. Refer to Note 12.
32

-- 35 of 66 --

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
When used in this report, the terms “The Coca-Cola Company,” “Company,” “we,” “us” and “our” mean The Coca-Cola Company and all entities included in our consolidated
financial statements.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Recoverability of Equity Method Investments and Indefinite-Lived Intangible Assets
Our Company faces many uncertainties and risks related to various economic, political and regulatory environments in the countries and territories in which we operate,
particularly in developing and emerging markets. Refer to the headings “Item 1A. Risk Factors” in Part I and “Our Business — Challenges and Risks” in Part II of our Annual
Report on Form 10-K for the year ended December 31, 2025, as well as the heading “Operations Review” below, for additional information related to our present business
environment. As a result, management must make numerous assumptions, which involve a significant amount of judgment, when performing impairment tests of equity method
investments and indefinite-lived intangible assets in various regions around the world. The performance of impairment tests involves critical accounting estimates. These
estimates require significant management judgment and include inherent uncertainties. Factors that management must estimate include, among others, the economic lives of the
assets, sales volume, pricing, royalty rates, cost of raw materials, delivery costs, long-term growth rates, discount rates, marketing spending, foreign currency exchange rates,
tax rates, capital spending and proceeds from the sale of assets. The variability of these factors depends on a number of conditions, and thus our accounting estimates may
change from period to period. These factors are even more difficult to estimate given the highly volatile global financial markets. As these factors are often interdependent and
may not change in isolation, we do not believe it is practicable or meaningful to present the impact of changing a single factor.
During the three months ended December 31, 2025, the operating results related to our BodyArmor sports performance and hydration beverage business, combined with lower
expectations of future performance compared to the original forecasts, triggered the need to update the Company’s impairment analysis, including a reassessment of the
business projections for the trademark. Based on this assessment, the Company concluded that the fair value of the trademark was less than its carrying value and recorded an
impairment charge of $960 million. The decrease in fair value was primarily driven by the revised projections of future operating results, including a slowing of the projected
long-term growth rate for the category, an intensifying competitive environment, and more focused innovation and international rollout plans. The remaining carrying value of
the trademark is $2,440 million. As of October 2, 2026, the fair value of this trademark approximates its carrying value. If the near-term operating results of this trademark do
not achieve our revised financial projections, or if the macroeconomic conditions change, causing the discount rate to increase without an offsetting increase in the operating
results, it is likely that we would be required to recognize an additional impairment charge. Management will continue to monitor the fair value of this trademark in future
periods.
OPERATIONS REVIEW
Sales of our ready-to-drink beverages are somewhat seasonal, with the second and third calendar quarters typically accounting for the highest sales volumes. The volume of
sales in the beverage business may be affected by weather conditions.
While our operations are primarily local, we remain subject to global trade dynamics, which may impact certain components of our cost structure as well as the cost structures
of our bottlers and our customers and may affect consumer sentiment across our markets.
Structural Changes, Acquired Brands and Newly Licensed Brands
In order to continually improve upon the Company’s operating performance, from time to time we engage in buying and selling ownership interests in bottling partners and
other manufacturing operations. In addition, we periodically acquire brands and their related operations or enter into license agreements for certain brands to supplement our
beverage offerings. These items impact our operating results and certain key metrics used by management in assessing the Company’s performance.
Unit case volume growth is a key metric used by management to evaluate the Company’s performance because it measures demand for our products at the consumer level. The
Company’s unit case volume represents the number of unit cases (or unit case equivalents) of Company beverage products directly or indirectly sold by the Company and its
bottling partners (collectively, “Coca-Cola system”) to customers or consumers and, therefore, reflects unit case volume for both consolidated and unconsolidated bottlers.
Refer to the heading “Beverage Volume” below.
Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in unit case equivalents) sold by, or
used in finished products sold by, the Company to its bottling partners or other customers. For our Costa non-ready-to-drink beverage products, concentrate sales volume
represents the amount of beverages, primarily measured in number of transactions (in all instances expressed in unit case equivalents), sold by the Company to customers or
consumers. Refer to the heading “Beverage Volume” below.
33

-- 36 of 66 --

When we analyze our net operating revenues, we generally consider the following factors: (1) volume growth (concentrate sales volume or unit case volume, as applicable); (2)
changes in price/mix; (3) foreign currency exchange rate fluctuations; and (4) acquisitions and divestitures (including structural changes as defined below), as applicable. Refer
to the heading “Net Operating Revenues” below. The Company sells concentrates and syrups to both consolidated and unconsolidated bottling partners. The ownership
structure of our bottling partners impacts the timing of recognizing concentrate revenue and concentrate sales volume. When we sell concentrates or syrups to our consolidated
bottling partners, we do not recognize the concentrate revenue or concentrate sales volume until the bottling partner has sold finished products manufactured from the
concentrates or syrups to a third party. When we sell concentrates or syrups to our unconsolidated bottling partners, we recognize the concentrate revenue and concentrate sales
volume when the concentrates or syrups are sold to the bottling partner. The subsequent sale of the finished products manufactured from the concentrates or syrups to a third
party does not impact the timing of recognizing the concentrate revenue or concentrate sales volume. When we account for an unconsolidated bottling partner as an equity
method investment, we eliminate the intercompany profit related to concentrate sales to the extent of our ownership interest, until the equity method investee has sold finished
products manufactured from the concentrates or syrups to a third party. We typically report unit case volume when finished products manufactured from the concentrates or
syrups are sold to a third party, regardless of our ownership interest in the bottling partner, if any.
We generally refer to acquisitions and divestitures of bottling operations as “structural changes,” which are a component of acquisitions and divestitures. Typically, structural
changes do not impact the Company’s unit case volume on a consolidated basis or at the geographic operating segment level. We recognize unit case volume for all sales of
Company beverage products, regardless of our ownership interest in the bottling partner, if any. However, the unit case volume reported by our Bottling Investments operating
segment is generally impacted by structural changes because it only includes the unit case volume of our consolidated bottling operations. Refer to Note 2 of Notes to
Consolidated Financial Statements for additional information on the Company’s acquisitions and divestitures.
“Acquired brands” refers to brands acquired during the past 12 months. Typically, the Company has not reported unit case volume or recognized concentrate sales volume
related to acquired brands in periods prior to the closing of a transaction. Therefore, the unit case volume and concentrate sales volume related to an acquired brand are
incremental to prior year volume. We generally do not consider the acquisition of a brand to be a structural change.
“Licensed brands” refers to brands not owned by the Company but for which we hold certain rights, generally including, but not limited to, distribution rights, and from which
we derive an economic benefit when the related products are sold. Typically, the Company has not reported unit case volume or recognized concentrate sales volume related to
a licensed brand in periods prior to the beginning of the term of a license agreement. Therefore, in the year that a license agreement is entered into, the unit case volume and
concentrate sales volume related to a licensed brand are incremental to prior year volume. We generally do not consider the licensing of a brand to be a structural change.
In May 2025, the Company refranchised our bottling operations in certain territories in India. The impact of this refranchising has been included as a structural change in our
analysis of net operating revenues on a consolidated basis as well as for the Bottling Investments and Asia Pacific operating segments for the nine months ended October 2,
2026. Additionally, in October 2025, the Company sold our finished product operations in Nigeria. The impact of this sale has been included as a divestiture in our analysis of
net operating revenues on a consolidated basis as well as for the EMEA operating segment for the three and nine months ended October 2, 2026.
Beverage Volume
We measure the volume of Company beverage products sold in two ways: (1) unit cases of finished products and (2) concentrate sales. As used in this report, “unit case” means
a unit of measurement equal to 192 U.S. fluid ounces of finished beverage (24 eight-ounce servings), with the exception of unit case equivalents for Costa non-ready-to-drink
beverage products, which are primarily measured in number of transactions; and “unit case volume” means the number of unit cases (or unit case equivalents) of Company
beverage products directly or indirectly sold by the Company and its bottling partners to customers or consumers. Unit case volume primarily consists of beverage products
bearing Company trademarks. Also included in unit case volume are certain brands licensed to, or distributed by, our Company, and brands owned by Coca-Cola system bottlers
for which our Company provides marketing support and from the sale of which we derive an economic benefit. In addition, unit case volume includes sales by certain joint
ventures in which the Company has an ownership interest. We believe unit case volume is one of the indicators of the underlying strength of the Coca-Cola system because it
measures demand for our products at the consumer level. The unit case volume numbers used in this report are derived based on estimates received by the Company from its
bottling partners and distributors. Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in
unit case equivalents) sold by, or used in finished beverages sold by, the Company to its bottling partners or other customers. For Costa non-ready-to-drink beverage products,
concentrate sales volume represents the amount of beverages, primarily measured in number of transactions (in all instances expressed in unit case equivalents), sold by the
Company to customers or consumers. Unit case volume and concentrate sales volume growth
34

-- 37 of 66 --

rates are not necessarily equal during any given period. Factors such as seasonality, bottlers’ inventory practices, supply point changes, timing of price increases, new product
introductions and changes in product mix can create differences between unit case volume and concentrate sales volume growth rates. In addition to these items, the impact of
unit case volume from certain joint ventures in which the Company has an ownership interest, but to which the Company does not sell concentrates, syrups, source waters or
powders/minerals, may give rise to differences between unit case volume and concentrate sales volume growth rates.
Information about our volume growth worldwide and for each of our operating segments is as follows:
Percent Change 2026 versus 2025
Three Months Ended
October 2, 2026 Nine Months Ended
October 2, 2026
Unit Cases 	Concentrate Sales 	Unit Cases 	Concentrate Sales
Worldwide 	5% 	6% 	4% 	6%
EMEA 	5 	6 	3 	4
Latin America 	6 	8 	3 	6
North America 	— 	2 	2 	5
Asia Pacific 	6 	8 	7 	10
Bottling Investments 	8 	N/A 	5 	N/A
Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only.
Geographic operating segment data reflects unit case volume growth for all bottlers, both consolidated and unconsolidated, and distributors in the applicable geographic areas. Unit case volume
growth for Costa retail stores is reflected in the EMEA operating segment data.
Unit case volume percent change is based on average daily sales. Unit case volume growth based on average daily sales is computed by comparing the average daily sales in each of the
corresponding periods. Average daily sales are the unit cases sold during the period divided by the number of days in the period.
Concentrate sales volume represents the amount of concentrates, syrups, source waters and powders/minerals (in all instances expressed in unit case equivalents) sold by, or used in finished
beverages sold by, the Company to its bottling partners or other customers and is not based on average daily sales. For Costa non-ready-to-drink beverage products, concentrate sales volume
represents the amount of beverages, primarily measured in number of transactions (in all instances expressed in unit case equivalents), sold by the Company to customers or consumers and is not
based on average daily sales. Each of our quarters, other than the fourth quarter, ends on the Friday closest to the last day of the corresponding quarterly calendar period. As a result, the first
quarter of 2026 had six additional days when compared to the first quarter of 2025, and the fourth quarter of 2026 will have six fewer days when compared to the fourth quarter of 2025.
After considering the impact of structural changes, unit case volume for Bottling Investments for the three and nine months ended October 2, 2026 increased 10% and 7%, respectively.
After considering the impact of divestiture activities, worldwide concentrate sales volume for the three months ended October 2, 2026 increased 7%.
Unit Case Volume
Although a significant portion of our Company’s net operating revenues is not based directly on unit case volume, we believe unit case volume performance is one of the
indicators of the underlying strength of the Coca-Cola system because it measures demand for our products at the consumer level.
Three Months Ended October 2, 2026 versus Three Months Ended September 26, 2025
Unit case volume in EMEA increased 5%, which included 6% growth in Trademark Coca-Cola, 5% growth in water, sports, coffee and tea, 3% growth in sparkling flavors, as
well as growth in energy drinks, partially offset by an 8% decline in juice, value-added dairy and plant-based beverages, which was driven by the impact of the sale of our
finished product operations in Nigeria in 2025. The operating segment’s volume performance included an increase in unit case volume of 8% in the Eurasia and Middle East
operating unit, 7% in the Africa operating unit and 2% in the Europe operating unit.
Unit case volume in Latin America increased 6%, which included 6% growth in Trademark Coca-Cola, 7% growth in water, sports, coffee and tea, 6% growth in sparkling
flavors, 2% growth in juice, value-added dairy and plant-based beverages, as well as growth in energy drinks. The operating segment’s volume performance included 3%
growth in Mexico, 6% growth in Brazil, 26% growth in Peru and 17% growth in Colombia.
Unit case volume in North America was even, which included 2% growth in Trademark Coca-Cola, 1% growth in juice, value-added dairy and plant-based beverages, as well
as growth in energy drinks, offset by a 4% decline in water, sports, coffee and tea as well as a 2% decline in sparkling flavors.
1,2,3 	4 	1,2,3 	4
6
5 	5
1
2
3
4
5
6
35

-- 38 of 66 --

Unit case volume in Asia Pacific increased 6%, which included 7% growth in both Trademark Coca-Cola and water, sports, coffee and tea, 4% growth in sparkling flavors, 3%
growth in juice, value-added dairy and plant-based beverages, as well as growth in energy drinks. The operating segment’s volume performance included 17% growth in the
India and Southwest Asia operating unit, 6% growth in both the Greater China and Mongolia and the ASEAN and South Pacific operating units, partially offset by a 5% decline
in the Japan and South Korea operating unit.
Unit case volume for Bottling Investments increased 8%, primarily driven by growth in India and Africa.
Nine Months Ended October 2, 2026 versus Nine Months Ended September 26, 2025
Unit case volume in EMEA increased 3%, which included 3% growth in Trademark Coca-Cola, 5% growth in water, sports, coffee and tea, 2% growth in sparkling flavors, as
well as growth in energy drinks, partially offset by an 11% decline in juice, value-added dairy and plant-based beverages, which was driven by the impact of the sale of our
finished product operations in Nigeria. The operating segment’s volume performance included an increase in unit case volume of 5% in both the Eurasia and Middle East and
Africa operating units and 2% growth in the Europe operating unit.
Unit case volume in Latin America increased 3%, which included 3% growth in Trademark Coca-Cola, 4% growth in water, sports, coffee and tea, 3% growth in sparkling
flavors, 1% growth in juice, value-added dairy and plant-based beverages, as well as growth in energy drinks. The operating segment’s volume performance included 5%
growth in Brazil, 16% growth in Peru, 15% growth in Colombia and 1% growth in Mexico, partially offset by a decline of 4% in Argentina.
Unit case volume in North America increased 2%, which included 4% growth in Trademark Coca-Cola, 2% growth in juice, value-added dairy and plant-based beverages, as
well as growth in energy drinks. Unit case volume in both sparkling flavors and water, sports, coffee and tea was even.
Unit case volume in Asia Pacific increased 7%, which included 7% growth in Trademark Coca-Cola, 8% growth in water, sports, coffee and tea, 6% growth in sparkling
flavors, 4% growth in juice, value-added dairy and plant-based beverages, as well as growth in energy drinks. The operating segment’s volume performance included 11%
growth in the India and Southwest Asia operating unit, 7% growth in the Greater China and Mongolia operating unit and 6% growth in the ASEAN and South Pacific operating
unit. Unit case volume in the Japan and South Korea operating unit was even.
Unit case volume for Bottling Investments increased 5%, primarily driven by growth in India and Africa, partially offset by the impact of refranchising certain territories of our
bottling operations in India.
Concentrate Sales Volume
During the three months ended October 2, 2026, worldwide concentrate sales volume increased 6% and unit case volume increased 5% compared to the three months ended
September 26, 2025. During the nine months ended October 2, 2026, worldwide concentrate sales volume increased 6% and unit case volume increased 4% compared to the
nine months ended September 26, 2025. Concentrate sales volume growth is calculated based on the amount sold during the reporting periods, which is impacted by the number
of days. Conversely, unit case volume growth is calculated based on average daily sales, which is not impacted by the number of days in the reporting periods. The first quarter
of 2026 had six additional days when compared to the first quarter of 2025, which contributed to the differences between concentrate sales volume and unit case volume growth
rates on a consolidated basis and for the individual operating segments during the nine months ended October 2, 2026. Additionally, the differences between concentrate sales
volume and unit case volume growth rates for the operating segments were impacted by the timing of concentrate shipments. We generally expect the differences between
concentrate sales volume and unit case volume growth rates to be minimal on a full year basis; however, for the full year 2026 we currently expect worldwide concentrate sales
volume growth to be slightly behind unit case volume growth.
36

-- 39 of 66 --

Net Operating Revenues
Three Months Ended October 2, 2026 versus Three Months Ended September 26, 2025
During the three months ended October 2, 2026, net operating revenues were $13,380 million, compared to $12,455 million during the three months ended September 26, 2025,
an increase of $925 million, or 7%.
The following table illustrates, on a percentage basis, the estimated impact of the factors resulting in the increase (decrease) in net operating revenues on a consolidated basis
and for each of our operating segments:
Percent Change 2026 versus 2025
Volume 	Price/Mix Foreign Currency
Fluctuations Acquisitions &
Divestitures 	Total
Consolidated 	7% 	1% 	1% 	(1)% 	7%
EMEA 	6 	1 	— 	(3) 	4
Latin America 	8 	7 	9 	— 	25
North America 	2 	1 	— 	— 	3
Asia Pacific 	8 	(2) 	(3) 	— 	4
Bottling Investments 	10 	3 	1 	— 	13
Note: Certain rows may not add due to rounding.
Represents the percent change in net operating revenues attributable to the increase (decrease) in concentrate sales volume for our geographic operating segments (expressed in unit case
equivalents) after considering the impact of acquisitions and divestitures, if any. For our Bottling Investments operating segment, this represents the percent change in net operating revenues
attributable to the increase (decrease) in unit case volume computed by comparing the total sales (rather than the average daily sales) in each of the corresponding periods after considering the
impact of structural changes, if any. Our Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only after considering the impact of structural
changes, if any. Refer to the heading “Beverage Volume” above.
Includes structural changes, if any. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above.
Refer to the heading “Beverage Volume” above for additional information related to changes in our unit case and concentrate sales volumes.
“Price/mix” refers to the change in net operating revenues caused by factors such as pricing actions taken by the Company and, where applicable, our bottling partners; the mix
of categories, products and packages sold; and the mix of channels and geographic territories where the sales occurred. Management believes that providing investors with
price/mix enhances their understanding about the combined impact that these items had on the Company’s net operating revenues. The impact of price/mix is calculated by
subtracting the change in net operating revenues resulting from volume increases or decreases, fluctuations in foreign currency exchange rates, and acquisitions and divestitures
from the total change in net operating revenues. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s
performance.
Price/mix had a 1% favorable impact on our consolidated net operating revenues. Price/mix was impacted by a variety of factors and events, including, but not limited to, the
following:
• EMEA — favorable pricing initiatives, including inflationary pricing, partially offset by unfavorable mix;
• Latin America — favorable pricing initiatives, including inflationary pricing, and favorable mix;
• North America — favorable pricing initiatives, partially offset by unfavorable mix;
• Asia Pacific — unfavorable mix; and
• Bottling Investments — favorable pricing initiatives, partially offset by unfavorable mix.
Fluctuations in foreign currency exchange rates, including the effects of our hedging activities, favorably impacted our consolidated net operating revenues by 1%. Net
operating revenues were favorably impacted by a weaker U.S. dollar compared to certain foreign currencies, including the Mexican peso, Brazilian real, South African rand and
Chinese yuan, which had a favorable impact on our Latin America, EMEA, Asia Pacific and Bottling Investments operating segments. The favorable impact of a weaker U.S.
dollar compared to the currencies listed above was partially offset by the impact of a stronger U.S. dollar compared to certain other foreign currencies, including the Japanese
yen, Indian rupee, euro and Turkish lira, which had an unfavorable impact on our Asia Pacific, EMEA and Bottling Investments operating segments. Refer to the heading
“Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.
1 	2
1
2
37

-- 40 of 66 --

“Acquisitions and divestitures” generally refers to acquisitions and divestitures of brands or businesses, some of which the Company considers to be structural changes. The
impact of acquisitions and divestitures is the difference between the change in net operating revenues and the change in what our net operating revenues would have been if we
removed the net operating revenues associated with an acquisition or a divestiture from either the current year or the prior year, as applicable. Management believes that
quantifying the impact that acquisitions and divestitures had on the Company’s net operating revenues provides investors with useful information to enhance their
understanding of the Company’s net operating revenue performance by improving their ability to compare our period-to-period results. Management considers the impact of
acquisitions and divestitures when evaluating the Company’s performance. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above for
additional information related to acquisitions and divestitures.
Nine Months Ended October 2, 2026 versus Nine Months Ended September 26, 2025
During the nine months ended October 2, 2026, net operating revenues were $39,232 million, compared to $36,119 million during the nine months ended September 26, 2025,
an increase of $3,113 million, or 9%.
The following table illustrates, on a percentage basis, the estimated impact of the factors resulting in the increase (decrease) in net operating revenues on a consolidated basis
and for each of our operating segments:
Percent Change 2026 versus 2025
Volume 	Price/Mix Foreign Currency
Fluctuations Acquisitions &
Divestitures 	Total
Consolidated 	6% 	1% 	2% 	(1)% 	9%
EMEA 	4 	2 	3 	(3) 	6
Latin America 	6 	4 	8 	— 	18
North America 	5 	2 	— 	— 	7
Asia Pacific 	10 	(6) 	(1) 	— 	3
Bottling Investments 	10 	1 	2 	(1) 	11
Note: Certain rows may not add due to rounding.
Represents the percent change in net operating revenues attributable to the increase (decrease) in concentrate sales volume for our geographic operating segments (expressed in unit case
equivalents) after considering the impact of acquisitions and divestitures, if any. For our Bottling Investments operating segment, this represents the percent change in net operating revenues
attributable to the increase (decrease) in unit case volume computed by comparing the total sales (rather than the average daily sales) in each of the corresponding periods after considering the
impact of structural changes, if any. Our Bottling Investments operating segment data reflects unit case volume growth for consolidated bottlers only after considering the impact of structural
changes, if any. Refer to the heading “Beverage Volume” above.
Includes structural changes, if any. Refer to the heading “Structural Changes, Acquired Brands and Newly Licensed Brands” above.
Refer to the heading “Beverage Volume” above for additional information related to changes in our unit case and concentrate sales volumes.
Price/mix had a 1% favorable impact on our consolidated net operating revenues. Price/mix was impacted by a variety of factors and events, including, but not limited to, the
following:
• EMEA — favorable pricing initiatives, including inflationary pricing, partially offset by unfavorable mix;
• Latin America — favorable pricing initiatives, including inflationary pricing, and favorable mix;
• North America — favorable pricing initiatives, partially offset by unfavorable mix;
• Asia Pacific — unfavorable mix, including affordability initiatives; and
• Bottling Investments — favorable pricing initiatives, partially offset by unfavorable mix.
Fluctuations in foreign currency exchange rates, including the effects of our hedging activities, favorably impacted our consolidated net operating revenues by 2%. Net
operating revenues were favorably impacted by a weaker U.S. dollar compared to certain foreign currencies, including the Mexican peso, Brazilian real, South African rand and
euro, which had a favorable impact on our Latin America, EMEA and Bottling Investments operating segments. The favorable impact of a weaker U.S. dollar compared to the
currencies listed above was partially offset by the impact of a stronger U.S. dollar compared to certain other foreign currencies, including the Indian rupee, Japanese yen,
Turkish lira and Argentine peso, which had an unfavorable impact on our Asia Pacific, EMEA, Latin America and Bottling Investments operating segments. Refer to the
heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.
1 	2
1
2
38

-- 41 of 66 --

Net operating revenue growth rates are impacted by sales volume; price/mix; foreign currency exchange rate fluctuations; and acquisitions and divestitures. The size and timing
of acquisitions and divestitures are not consistent from period to period. Based on current spot rates and our hedging coverage in place, we expect foreign currency exchange
rate fluctuations will have a favorable impact on our full year 2026 net operating revenues.
Gross Profit Margin
Gross profit margin is a ratio calculated by dividing gross profit by net operating revenues. Management believes gross profit margin provides investors with useful information
related to the profitability of our business prior to considering all of the selling, general and administrative expenses and other operating charges incurred. Management uses
this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.
Our gross profit margin increased to 63.2% for the three months ended October 2, 2026, compared to 61.5% for the three months ended September 26, 2025. Our gross profit
margin increased to 63.0% for the nine months ended October 2, 2026, compared to 62.1% for the nine months ended September 26, 2025. The increases were primarily due to
the favorable impact of pricing initiatives and foreign currency exchange rate fluctuations, commodity cost stabilization, as well as the impact of the sale of our finished product
operations in Nigeria.
Selling, General and Administrative Expenses
During the three months ended October 2, 2026, selling, general and administrative expenses were $3,975 million, compared to $3,618 million during the three months ended
September 26, 2025, an increase of $357 million, or 10%. The increase was primarily due to increased marketing spending and increased annual incentive expense due to
timing.
During the nine months ended October 2, 2026, selling, general and administrative expenses were $11,167 million, compared to $10,322 million during the nine months ended
September 26, 2025, an increase of $845 million, or 8%. The increase was primarily due to increased marketing spending, partially offset by lower annual incentive expense.
Additionally, during the nine months ended October 2, 2026, foreign currency exchange rate fluctuations increased selling, general and administrative expenses by 2%.
Advertising expenses for the three months ended October 2, 2026 and September 26, 2025 were $1,777 million and $1,523 million, respectively. Advertising expenses for the
nine months ended October 2, 2026 and September 26, 2025 were $4,719 million and $3,940 million, respectively.
Other Operating Charges
Other operating charges incurred by our operating segments and Corporate were as follows (in millions):
Three Months Ended 	Nine Months Ended
October 2,
2026 September 26,
2025 October 2,
2026 September 26,
2025
EMEA 	$ 	— $ 	— 	$ 	— $ 	—
Latin America 	— 	— 	— 	31
North America 	6 	— 	16 	—
Asia Pacific 	— 	— 	— 	—
Bottling Investments 	— 	— 	— 	—
Corporate 	4 	58 	38 	171
Total 	$ 	10 $ 	58 	$ 	54 $ 	202
During the three months ended October 2, 2026, the Company recorded other operating charges of $10 million. These charges consisted of $6 million related to North America
modernization initiatives and $4 million for the amortization of noncompete agreements related to the BodyArmor acquisition.
During the nine months ended October 2, 2026, the Company recorded other operating charges of $54 million. These charges consisted of $19 million related to an
indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $16 million related to North America modernization initiatives,
$11 million for the amortization of noncompete agreements related to the BodyArmor acquisition and $8 million related to tax litigation expense.
During the three months ended September 26, 2025, the Company recorded other operating charges of $58 million. These charges included $27 million related to an
indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $24 million related to the Company’s productivity and reinvestment
program, $4 million for the amortization of noncompete agreements related to the BodyArmor acquisition and $3 million related to tax litigation expense.
39

-- 42 of 66 --

During the nine months ended September 26, 2025, the Company recorded other operating charges of $202 million. These charges consisted of $47 million related to the
remeasurement of our contingent consideration liability to fair value in conjunction with our acquisition of fairlife in 2020, which brought the total liability to $6,173 million
and was paid in March 2025. Additionally, other operating charges included $63 million related to the Company’s productivity and reinvestment program, $35 million related to
an indemnification agreement entered into as a part of the refranchising of certain of our bottling operations, $31 million related to the impairment of a trademark in Latin
America, $11 million for the amortization of noncompete agreements related to the BodyArmor acquisition, $8 million related to tax litigation expense and $7 million of
transaction costs related to the refranchising of our bottling operations in certain territories in India.
Refer to Note 2 of Notes to Consolidated Financial Statements for additional information on our divestiture activities. Refer to Note 9 of Notes to Consolidated Financial
Statements for additional information on the tax litigation. Refer to Note 15 of Notes to Consolidated Financial Statements for additional information on the impairment charge.
Operating Income and Operating Margin
Information about our operating income contribution by operating segment and Corporate on a percentage basis is as follows:
Three Months Ended 	Nine Months Ended
October 2,
2026 September 26,
2025 October 2,
2026 September 26,
2025
EMEA 	26.2% 	27.5% 	27.7% 	29.3%
Latin America 	25.8 	22.5 	25.0 	23.1
North America 	39.6 	42.2 	37.5 	38.9
Asia Pacific 	12.6 	13.2 	13.0 	15.0
Bottling Investments 	4.6 	1.4 	3.6 	2.0
Corporate 	(8.8) 	(6.8) 	(6.8) 	(8.3)
Total 	100.0% 	100.0% 	100.0% 	100.0%
Operating margin is a ratio calculated by dividing operating income by net operating revenues. Management believes operating margin provides investors with useful
information related to the profitability of our business after considering all of the selling, general and administrative expenses and other operating charges
incurred. Management uses this measure in making financial, operating and planning decisions and in evaluating the Company’s performance.
Information about our operating margin on a consolidated basis and for each of our operating segments and Corporate is as follows:
Three Months Ended 	Nine Months Ended
October 2,
2026
September 26,
2025
October 2,
2026
September 26,
2025
Consolidated 	33.4% 	32.0% 	34.4% 	33.0%
EMEA 	39.3 	38.9 	42.1 	42.0
Latin America 	58.9 	57.1 	61.5 	59.5
North America 	32.8 	32.0 	32.3 	31.7
Asia Pacific 	37.6 	36.3 	39.8 	42.4
Bottling Investments 	13.4 	4.2 	10.4 	5.6
Corporate 	* 	* 	* 	*
* Calculation is not meaningful.
Three Months Ended October 2, 2026 versus Three Months Ended September 26, 2025
During the three months ended October 2, 2026, operating income was $4,465 million, compared to $3,982 million during the three months ended September 26, 2025, an
increase of $483 million, or 12%. The increase was primarily driven by an increase in concentrate sales volume of 7%, favorable price/mix, lower commodity costs, lower other
operating charges and a favorable foreign currency exchange rate impact of 3%, partially offset by increased marketing spending and higher operating expenses.
Fluctuations in foreign currency exchange rates, including the effects of our hedging activities, favorably impacted consolidated operating income by 3% due to a weaker U.S.
dollar compared to certain foreign currencies, including the Mexican peso and Brazilian real, which had a favorable impact on our Latin America operating segment. The
favorable impact of a weaker U.S. dollar compared to the currencies listed above was partially offset by the impact of a stronger U.S. dollar compared to certain
40

-- 43 of 66 --

other foreign currencies, including the Japanese yen and euro, which had an unfavorable impact on our Asia Pacific and EMEA operating segments. Refer to the heading
“Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.
The EMEA operating segment reported operating income of $1,171 million and $1,097 million for the three months ended October 2, 2026 and September 26, 2025,
respectively. The increase in operating income was primarily driven by an increase in concentrate sales volume of 6%, favorable price/mix and lower commodity costs, partially
offset by increased marketing spending and higher operating expenses.
Latin America reported operating income of $1,152 million and $897 million for the three months ended October 2, 2026 and September 26, 2025, respectively. The increase in
operating income was primarily driven by an increase in concentrate sales volume of 8%, favorable price/mix, lower commodity costs, lower operating expenses and a
favorable foreign currency exchange rate impact of 14%, partially offset by increased marketing spending.
Operating income for North America for the three months ended October 2, 2026 and September 26, 2025 was $1,766 million and $1,681 million, respectively. The increase in
operating income was primarily driven by an increase in concentrate sales volume of 2%, favorable price/mix and decreased marketing spending partly due to timing, partially
offset by higher commodity costs, higher operating expenses and higher other operating charges.
Asia Pacific’s operating income for the three months ended October 2, 2026 and September 26, 2025 was $563 million and $521 million, respectively. The increase in operating
income was primarily driven by an increase in concentrate sales volume of 8%, partially offset by unfavorable price/mix and an unfavorable foreign currency exchange rate
impact of 6%.
Bottling Investments’ operating income for the three months ended October 2, 2026 and September 26, 2025 was $205 million and $57 million, respectively. The increase in
operating income was primarily driven by an increase in unit case volume of 10%, favorable price/mix, lower commodity costs and lower operating expenses, partially offset
by an unfavorable foreign currency exchange rate impact of 2%.
Corporate’s operating loss for the three months ended October 2, 2026 and September 26, 2025 was $392 million and $271 million, respectively. This increase is primarily a
result of higher annual incentive expense due to timing and increased marketing expenses, partially offset by lower other operating charges.
Nine Months Ended October 2, 2026 versus Nine Months Ended September 26, 2025
During the nine months ended October 2, 2026, operating income was $13,496 million, compared to $11,921 million during the nine months ended September 26, 2025, an
increase of $1,575 million, or 13%. The increase was primarily driven by an increase in concentrate sales volume of 6%, favorable price/mix, lower operating expenses, lower
other operating charges and a favorable foreign currency exchange rate impact of 4%, partially offset by higher commodity costs and increased marketing spending.
Fluctuations in foreign currency exchange rates, including the effects of our hedging activities, favorably impacted consolidated operating income by 4% due to a weaker U.S.
dollar compared to certain foreign currencies, including the Mexican peso, Brazilian real and euro, which had a favorable impact on our Latin America and EMEA operating
segments. The favorable impact of a weaker U.S. dollar compared to the currencies listed above was partially offset by the impact of a stronger U.S. dollar compared to certain
other foreign currencies, including the Argentine peso, Japanese yen, Indian rupee and Turkish lira, which had an unfavorable impact on our Latin America, Asia Pacific,
EMEA and Bottling Investments operating segments. Refer to the heading “Liquidity, Capital Resources and Financial Position — Foreign Exchange” below.
The EMEA operating segment reported operating income of $3,739 million and $3,487 million for the nine months ended October 2, 2026 and September 26, 2025,
respectively. The increase in operating income was primarily driven by an increase in concentrate sales volume of 4%, favorable price/mix, lower commodity costs and a
favorable foreign currency exchange rate impact of 3%, partially offset by increased marketing spending and higher operating expenses.
Latin America reported operating income of $3,367 million and $2,758 million for the nine months ended October 2, 2026 and September 26, 2025, respectively. The increase
in operating income was primarily driven by an increase in concentrate sales volume of 6%, favorable price/mix, lower commodity costs, lower operating expenses, lower other
operating charges and a favorable foreign currency exchange rate impact of 12%, partially offset by increased marketing spending.
Operating income for North America for the nine months ended October 2, 2026 and September 26, 2025 was $5,067 million and $4,643 million, respectively. The increase in
operating income was primarily driven by an increase in concentrate sales volume of 5%, favorable price/mix and lower operating expenses, partially offset by higher
commodity costs, increased marketing spending and higher other operating charges.
Asia Pacific’s operating income for the nine months ended October 2, 2026 and September 26, 2025 was $1,755 million and $1,792 million, respectively. The decrease in
operating income was primarily driven by unfavorable price/mix, higher
41

-- 44 of 66 --

commodity costs and increased marketing spending, partially offset by an increase in concentrate sales volume of 10% and lower operating expenses.
Bottling Investments’ operating income for the nine months ended October 2, 2026 and September 26, 2025 was $487 million and $235 million, respectively. The increase in
operating income was primarily driven by an increase in unit case volume of 10%, favorable price/mix, lower commodity costs and lower operating expenses, partially offset
by increased marketing spending.
Corporate’s operating loss for the nine months ended October 2, 2026 and September 26, 2025 was $919 million and $994 million, respectively. This decrease is primarily a
result of lower operating expenses due to lower annual incentive expense and lower other operating charges, partially offset by increased marketing expenses.
Based on current spot rates and our hedging coverage in place, we expect foreign currency exchange rate fluctuations will have a favorable impact on our full year 2026
operating income.
Interest Income
During the three months ended October 2, 2026, interest income was $224 million, compared to $185 million during the three months ended September 26, 2025, an increase of
$39 million, or 21%. During the nine months ended October 2, 2026, interest income was $644 million, compared to $553 million during the nine months ended September 26,
2025, an increase of $91 million, or 17%. The increases were primarily driven by higher average investment balances.
Interest Expense
During the three months ended October 2, 2026, interest expense was $354 million, compared to $391 million during the three months ended September 26, 2025, a decrease of
$37 million, or 9%. During the nine months ended October 2, 2026, interest expense was $1,098 million, compared to $1,223 million during the nine months ended September
26, 2025, a decrease of $125 million, or 10%. The decreases were primarily due to lower average short-term debt balances.
Equity Income (Loss) — Net
During the three months ended October 2, 2026, equity income was $653 million, compared to equity income of $644 million during the three months ended September 26,
2025, an increase of $9 million, or 1%. During the nine months ended October 2, 2026, equity income was $1,641 million, compared to equity income of $1,556 million during
the nine months ended September 26, 2025, an increase of $85 million, or 5%. These increases reflect, among other items, the impact of more favorable operating results
reported by certain of our equity method investees, and a favorable foreign currency exchange rate impact. These favorable impacts were partially offset by the increase of net
charges resulting from the Company’s proportionate share of significant operating and nonoperating items recorded by certain of our equity method investees, and the impact of
the sale of our ownership interests in certain equity method investees in 2025.
Other Income (Loss) — Net
Three Months Ended October 2, 2026 versus Three Months Ended September 26, 2025
During the three months ended October 2, 2026, other income (loss) — net was a loss of $155 million. The Company recorded expense of $194 million related to the non-
service cost components of net periodic benefit cost, which included charges of $167 million and $25 million for a settlement loss and special termination benefits, respectively,
related to a non-U.S. pension plan and foreign currency exchange losses of $29 million. Other income (loss) — net also included $14 million of costs related to our trade
accounts receivable factoring program. Additionally, other income (loss) — net included a net gain of $37 million related to realized and unrealized gains and losses on equity
securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities and dividend income of $44 million. The Company also recorded a
$5 million reduction in the previously recorded impairment charge related to our bottling operations in Africa, which are held for sale. This reduction is based on management’s
revised estimates.
During the three months ended September 26, 2025, other income (loss) — net was a loss of $237 million. The Company recorded a charge of $393 million related to certain
operations held for sale in Nigeria, $13 million of costs related to our trade accounts receivable factoring program, net foreign currency exchange losses of $11 million and a
charge of $8 million related to the refranchising of certain bottling operations in Ghana. Additionally, the Company recognized a net gain of $151 million related to realized and
unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities, and dividend income of
$36 million. Other income (loss) — net also included income of $4 million related to the non-service cost components of net periodic benefit cost.
42

-- 45 of 66 --

Refer to Note 2 of Notes to Consolidated Financial Statements for additional information on our bottling operations in Africa and our divestiture activities. Refer to Note 4 of
Notes to Consolidated Financial Statements for additional information on equity and debt securities. Refer to Note 13 of Notes to Consolidated Financial Statements for
additional information on net periodic benefit cost or income. Refer to Note 15 of Notes to Consolidated Financial Statements for additional information on the impairment
charges and the bottling operations in Ghana.
Nine Months Ended October 2, 2026 versus Nine Months Ended September 26, 2025
During the nine months ended October 2, 2026, other income (loss) — net was income of $236 million. The Company recognized a net gain of $338 million related to realized
and unrealized gains and losses on equity securities and trading debt securities as well as realized gains and losses on available-for-sale debt securities and dividend income of
$115 million. Additionally, other income (loss) — net included expense of $196 million related to the non-service cost components of net periodic benefit cost, which included
charges of $167 million and $25 million for a settlement loss and special termination benefits, respectively, related to a non-U.S. pension plan. The Company also recorded net
foreign currency exchange losses of $36 million and a $61 million reduction in the previously recorded impairment charge related to our bottling operations in Africa, which are
held for sale. This reduction is based on management’s revised estimates. Other income (loss) — net also included $41 million of costs related to our trade accounts receivable
factoring program.
During the nine months ended September 26, 2025, other income (loss) — net was income of $229 million. The Company recognized a gain of $331 million related to the sale
of a portion of our ownership interest in CCEP, a net gain of $295 million related to realized and unrealized gains and losses on equity securities and trading debt securities as
well as realized gains and losses on available-for-sale debt securities, dividend income of $127 million and a gain of $102 million related to the refranchising of our bottling
operations in certain territories in India. Additionally, the Company recorded a charge of $393 million related to certain operations held for sale in Nigeria as well as other-than-
temporary impairment charges of $40 million related to an equity method investee in Latin America and $25 million related to a joint venture in Latin America. Other income
(loss) — net also included $49 million of costs related to our trade accounts receivable factoring program, a charge of $36 million related to the refranchising of certain bottling
operations in Ghana, net foreign currency exchange losses of $31 million and expense of $26 million related to the non-service cost components of net periodic benefit cost,
which included charges of $25 million and $11 million for special termination benefits and a curtailment loss, respectively, related to non-U.S. pension activity.
Refer to Note 2 of Notes to Consolidated Financial Statements for additional information on our bottling operations in Africa and our divestiture activities. Refer to Note 4 of
Notes to Consolidated Financial Statements for additional information on equity and debt securities. Refer to Note 13 of Notes to Consolidated Financial Statements for
additional information on our pension activities. Refer to Note 15 of Notes to Consolidated Financial Statements for additional information on the impairment charges and the
bottling operations in Ghana.
Income Taxes
The Company recorded income taxes of $777 million (16.1% effective tax rate) and $500 million (11.9% effective tax rate) during the three months ended October 2, 2026 and
September 26, 2025, respectively. The Company recorded income taxes of $2,459 million (16.5% effective tax rate) and $2,215 million (17.0% effective tax rate) during the
nine months ended October 2, 2026 and September 26, 2025, respectively.
The Company’s effective tax rates for the three and nine months ended October 2, 2026 and September 26, 2025 vary from the statutory U.S. federal tax rate of 21.0%,
primarily due to the tax impact of significant operating and nonoperating items, as described in Note 12 of Notes to Consolidated Financial Statements, along with the tax
benefits of having significant earnings generated outside of the United States and significant earnings generated in investments accounted for under the equity method, both of
which are generally taxed at rates lower than the statutory U.S. federal tax rate.
The Company’s effective tax rates for the three and nine months ended October 2, 2026 included $172 million and $491 million, respectively, of net tax benefits related to
various discrete tax items, including net interest income of $57 million and $155 million, respectively, related to the IRS Tax Litigation Deposit recorded in the line item
income taxes in our consolidated statements of income, in accordance with our accounting policy. The Company’s effective tax rates for the three and nine months ended
October 2, 2026 also included net tax benefits of $117 million and $298 million, respectively, primarily related to return to provision adjustments.
The Company’s effective tax rates for the three and nine months ended September 26, 2025 included $442 million and $597 million, respectively, of net tax benefits related to
various discrete tax items, including net interest income of $55 million and $162 million, respectively, related to the IRS Tax Litigation Deposit recorded in the line item
income taxes in our consolidated statements of income, in accordance with our accounting policy. Also included were tax benefits of $258 million and $344 million,
respectively, related to changes in the Company’s indefinite reinvestment assertion and reassessments of the realizability of deferred tax assets for certain foreign entities.
43

-- 46 of 66 --

We are currently in litigation with the IRS for tax years 2007 through 2009. Refer to Note 9 of Notes to Consolidated Financial Statements for additional information on the tax
litigation.
At the end of each quarter, we make our best estimate of the effective tax rate expected to be applicable for the full fiscal year. This estimate reflects, among other items, our
best estimate of operating results and foreign currency exchange rates. Based on current tax laws, including the impact of several countries enacting global minimum tax
regulations, the Company’s effective tax rate in 2026 is expected to be approximately 19.7% before considering the potential impact of any significant operating and
nonoperating items that may affect our effective tax rate. This rate does not include the impact of the ongoing tax litigation with the IRS, if the Company were not to prevail.
Many jurisdictions have enacted legislation and adopted policies resulting from the Organization for Economic Co-operation and Development’s (“OECD”) Anti-Base Erosion
and Profit Shifting project. The OECD is currently coordinating a two-pillared project on behalf of the Group of Twenty (G20) and other participating countries which would
grant additional taxing rights over profits earned by multinational enterprises to the countries in which their products are sold and services rendered. Pillar One would allow
countries to reallocate a portion of profits earned by multinational businesses with an annual global revenue exceeding €20 billion and a profit margin of over 10% to applicable
market jurisdictions. While the OECD issued draft language for the international implementation of Pillar One in October 2023, both the substantive rules and implementation
process remain under discussion at the OECD, so the timetable for any implementation remains uncertain.
In December 2021, the OECD issued Pillar Two model rules, which would establish a global per-country minimum tax of 15%, and the European Union has approved a
directive requiring member states to incorporate similar provisions into their respective domestic laws. The directive requires, with certain limited exceptions, the rules to
initially become effective for fiscal years starting on or after December 31, 2023. Numerous countries have enacted legislation that implemented certain aspects of Pillar Two
effective January 1, 2024, or adopted legislation that became effective in 2025, while additional jurisdictions may enact similar legislation in the future. In June 2025, the Group
of Seven (G7) released a statement announcing an understanding of a potential side-by-side system approach to the Pillar Two framework that would exclude U.S.-parented
groups from certain Pillar Two provisions in recognition of existing U.S. minimum tax rules. In January 2026, the OECD issued further administrative guidance introducing a
side‑by‑side framework under Pillar Two, largely exempting U.S.-headquartered companies from the application of Pillar Two. The OECD and implementing countries are
expected to continue to make further revisions to their legislation and release additional guidance intended to adopt this side-by-side framework into law in each of the member
countries. The Company will continue to monitor developments to determine any potential impact in the countries in which we operate.
LIQUIDITY, CAPITAL RESOURCES AND FINANCIAL POSITION
We believe our ability to generate cash flows from operating activities is one of the fundamental strengths of our business. Refer to the heading “Cash Flows from Operating
Activities” below. The Company does not typically raise capital through the issuance of stock. Instead, we use debt financing to lower our overall cost of capital and increase
our return on shareowners’ equity. Refer to the heading “Cash Flows from Financing Activities” below. We have a history of borrowing funds both domestically and
internationally at reasonable interest rates, and we expect to be able to continue to borrow funds at reasonable rates over the long term. Our debt financing also includes the use
of a commercial paper program. We currently have the ability to borrow funds in this market at levels that are consistent with our debt financing strategy, and we expect to
continue to be able to do so in the future. The Company regularly reviews its optimal mix of short-term and long-term debt.
The Company’s cash, cash equivalents, short-term investments and marketable securities totaled $16.6 billion as of October 2, 2026. In addition to these funds, our commercial
paper program, and our ability to issue long-term debt, we had $6.6 billion in unused backup lines of credit for general corporate purposes as of October 2, 2026. These backup
lines of credit expire at various times through 2031.
Our current payment terms with the majority of our suppliers are 120 days. Certain financial institutions offer a voluntary supply chain finance program which enables our
suppliers, at their sole discretion, to sell their receivables from the Company to these financial institutions on a non-recourse basis at a rate that leverages our credit rating and
thus may be more beneficial to them. We do not believe there is a risk that our payment terms will be shortened in the near future. Refer to Note 7 of Notes to Consolidated
Financial Statements for additional information.
44

-- 47 of 66 --

The Company has a trade accounts receivable factoring program in certain countries. Under this program, we can elect to sell trade accounts receivables to unaffiliated financial
institutions at a discount. In these factoring arrangements, for ease of administration, the Company collects customer payments related to the factored receivables and remits
those payments to the financial institutions. The Company sold $10,629 million and $11,822 million of trade accounts receivables under this program during the nine months
ended October 2, 2026 and September 26, 2025, respectively. The costs of factoring such receivables were $41 million and $49 million for the nine months ended October 2,
2026 and September 26, 2025, respectively. The cash received from the financial institutions is reflected within the operating activities section of our consolidated statement of
cash flows.
Our current capital allocation priorities are as follows: investing wisely to support our business operations, continuing to grow our dividend payment, enhancing our beverage
portfolio and capabilities through consumer-centric acquisitions and using excess cash to repurchase shares over time. We currently expect 2026 capital expenditures to be
approximately $2.2 billion. During 2026, we expect to repurchase shares to offset dilution resulting from employee stock-based compensation.
We are currently in litigation with the IRS for tax years 2007 through 2009. On November 18, 2020, the Tax Court issued the Opinion in which it predominantly sided with the
IRS. On November 8, 2023, the Tax Court issued a supplemental opinion, siding with the IRS in concluding both that certain U.S. tax regulations (known as the blocked-
income regulations) that address the effect of certain Brazilian legal restrictions on royalty payments by the Company’s licensee in Brazil apply to the Company’s operations
and that the Tax Court opinion in the 3M case controlled as to the validity of those regulations. On October 1, 2025, the U.S. Court of Appeals for the Eighth Circuit issued an
opinion reversing the judgment of the Tax Court in the 3M case. In its decision, the court concluded that the blocked-income regulation was inconsistent with IRC Section 482
and that the IRS therefore could not reallocate income from 3M’s subsidiary in Brazil to 3M in contravention of Brazilian restrictions on the payment of royalties. Further, the
U.S. Court of Appeals for the Eighth Circuit specifically rejected the IRS’ argument that the ability of 3M’s subsidiary in Brazil to pay dividends, rather than royalties, meant
that royalty income should not be treated as blocked. Both of these conclusions are highly supportive of the Company’s position in its case and reinforce its prior conclusions.
On August 2, 2024, the Tax Court entered a decision reflecting additional federal income tax of $2.7 billion for the 2007 through 2009 tax years. With applicable interest, the
total liability for the 2007 through 2009 tax years resulting from the Tax Court’s decision is $6.0 billion, for which the IRS issued the Company invoices on September 3, 2024.
The Company paid the IRS Tax Litigation Deposit on September 10, 2024, which stopped interest from accruing on the additional tax due for the 2007 through 2009 tax years.
That amount, plus interest earned, would be refunded in full or in part if the Company’s tax positions are ultimately sustained on appeal. For the three and nine months ended
October 2, 2026, the Company recorded net interest income of $57 million and $155 million, respectively, and for the three and nine months ended September 26, 2025, the
Company recorded net interest income of $55 million and $162 million, respectively, related to this tax payment in the line item income taxes in our consolidated statements of
income, in accordance with our accounting policy. The payment of the IRS invoices and the related accrued interest were recorded in the line item other noncurrent assets in our
consolidated balance sheets as of October 2, 2026 and December 31, 2025. On October 22, 2024, the Company appealed the Tax Court’s decision to the U.S. Court of Appeals
for the Eleventh Circuit. The Company filed its principal appellate brief with the U.S. Court of Appeals for the Eleventh Circuit on March 12, 2025. The IRS filed its appellate
brief on July 7, 2025. The Company filed its reply brief on August 27, 2025. The U.S. Court of Appeals for the Eleventh Circuit heard the case on June 25, 2026.
The Company strongly disagrees with the IRS’ positions and the portions of the Opinions affirming such positions and intends to vigorously defend our positions utilizing every
available avenue of appeal. While the Company believes that it is more likely than not that we will ultimately prevail in this litigation upon appeal, it is possible that all, or
some portion of, the adjustments proposed by the IRS and sustained by the Tax Court could ultimately be upheld. In that event, the Company would not receive a refund of the
applicable portion or all of the $6.0 billion it paid in response to the IRS invoices issued in September 2024 and the related accrued interest receivable of $589 million as of
October 2, 2026. Additionally, the Company would likely be subject to significant additional liabilities for subsequent years, which could have a material adverse impact on the
Company’s financial position, results of operations and cash flows. The Company estimates that the potential aggregate remaining incremental tax and interest liability for the
tax years 2010 through 2025 could be approximately $14 billion as of December 31, 2025. Additional income tax and interest on any unpaid potential liabilities for the 2010
through 2025 tax years would continue to accrue until the time any such potential liability, or portion thereof, were to be paid. The Company estimates the impact of the
continued application of the methodology asserted by the IRS and affirmed in the Opinions for the three and nine months ended October 2, 2026 would increase the potential
aggregate incremental tax and interest liability by approximately $450 million and $1.4 billion, respectively. Refer to Note 9 of Notes to Consolidated Financial Statements for
additional information on the tax litigation.
While we believe it is more likely than not that we will prevail in the tax litigation discussed above, we are confident that, between our ability to generate cash flows from
operating activities and our ability to borrow funds at reasonable interest rates, we can manage the range of possible outcomes in the final resolution of the matter.
45

-- 48 of 66 --

Based on all of the aforementioned factors, the Company believes its current liquidity position is strong and will continue to be sufficient to fund our operating activities and
cash commitments for investing and financing activities for the foreseeable future.
Cash Flows from Operating Activities
Net cash provided by operating activities during the nine months ended October 2, 2026 and September 26, 2025 was $12,471 million and $3,652 million, respectively. The
increase was primarily driven by strong cash operating results, a benefit of the trade accounts receivable factoring program in the current year, lower income tax payments, a
favorable impact due to foreign currency exchange rate fluctuations, timing of working capital initiatives, lower net interest payments and lower annual incentive payments.
These items were partially offset by higher prior year transfers of surplus non-U.S. plan assets from pension trusts to general assets of the Company, higher restructuring
payments and unfavorable hedging activity.
Additionally, the activity in 2025 included $6,069 million of the $6,173 million final milestone payment for fairlife that was made during the nine months ended September 26,
2025. Refer to Note 12 of Notes to Consolidated Financial Statements for additional information on our milestone payment for fairlife.
Cash Flows from Investing Activities
Net cash provided by investing activities during the nine months ended October 2, 2026 and September 26, 2025 was $1,161 million and $977 million, respectively.
Purchases of Investments and Proceeds from Disposals of Investments
During the nine months ended October 2, 2026, purchases of investments were $3,706 million and proceeds from disposals of investments were $5,952 million, resulting in a
net cash inflow of $2,246 million. During the nine months ended September 26, 2025, purchases of investments were $3,292 million and proceeds from disposals of
investments were $4,300 million, resulting in a net cash inflow of $1,008 million. This activity primarily represents the purchases of, and proceeds from the disposals of,
investments in marketable securities and short-term investments that were made as part of the Company’s overall cash management strategy. Also included in this activity are
purchases of, and proceeds from the disposals of, investments held by our captive insurance companies. Refer to Note 4 of Notes to Consolidated Financial Statements for
additional information on our investments.
Acquisitions of Businesses, Equity Method Investments and Nonmarketable Securities
During the nine months ended October 2, 2026 and September 26, 2025, the Company’s acquisitions of businesses, equity method investments and nonmarketable securities
totaled $204 million and $356 million, respectively. The activity during the nine months ended October 2, 2026 and September 26, 2025 included additional investments of
$112 million and $54 million, respectively, in an equity method investee in Japan. The activity during the nine months ended October 2, 2026 and September 26, 2025 also
included $75 million and $271 million, respectively, of investments in alternative energy limited partnerships. Refer to Note 14 of Notes to Consolidated Financial Statements
for additional information on these investments.
Proceeds from Disposals of Businesses, Equity Method Investments and Nonmarketable Securities
During the nine months ended October 2, 2026 and September 26, 2025, proceeds from disposals of businesses, equity method investments and nonmarketable securities were
$1 million and $1,020 million, respectively. The activity during the nine months ended September 26, 2025 primarily related to the sale of a portion of our ownership interest in
CCEP and the refranchising of certain of our bottling operations. Refer to Note 2 of Notes to Consolidated Financial Statements.
Purchases of Property, Plant and Equipment
Purchases of property, plant and equipment during the nine months ended October 2, 2026 and September 26, 2025 were $1,063 million and $1,230 million, respectively.
Other Investing Activities
During the nine months ended October 2, 2026 and September 26, 2025, the total cash inflow was $271 million and $214 million, respectively. The activity during the nine
months ended October 2, 2026 included the return of an advance payment of $184 million to acquire additional shares in an equity method investee in Japan. The activity
during the nine months ended September 26, 2025 included $139 million related to the reimbursement of advance payments made to finance the construction of leased assets.
46

-- 49 of 66 --

Cash Flows from Financing Activities
Net cash used in financing activities during the nine months ended October 2, 2026 and September 26, 2025 was $10,546 million and $3,088 million, respectively.
Loans, Notes Payable and Long-Term Debt
The Company made payments of debt of $3,165 million during the nine months ended October 2, 2026, which consisted of $1,031 million of payments related to commercial
paper and short-term debt with maturities of 90 days or less, $500 million of payments related to commercial paper and short-term debt with maturities greater than 90 days and
payments of long-term debt of $1,634 million.
During the nine months ended September 26, 2025, the Company had issuances of debt of $4,854 million, which consisted of $764 million of net issuances of commercial
paper and short-term debt with maturities of 90 days or less, $3,442 million of issuances of commercial paper and short-term debt with maturities greater than 90 days and long-
term debt issuances of $648 million, net of related discounts and issuance costs.
The Company made payments of debt of $4,166 million during the nine months ended September 26, 2025, which consisted of $3,427 million of payments related to
commercial paper and short-term debt with maturities greater than 90 days and payments of long-term debt of $739 million.
Issuances of Stock
The issuances of stock during the nine months ended October 2, 2026 and September 26, 2025 were related to the exercise of stock options by employees.
Purchases of Stock for Treasury
During the nine months ended October 2, 2026, the total cash outflow for treasury stock purchases was $900 million. The Company repurchased 10.0 million shares of common
stock under the share repurchase plan authorized by our Board of Directors. These shares were repurchased at an average cost of $78.77 per share, for a total cost of $787
million. In addition to shares repurchased under the share repurchase plan, the Company’s treasury stock activity included shares surrendered to the Company to pay the
exercise price and/or to satisfy tax withholding obligations in connection with stock swap exercises of employee stock options and/or the vesting of restricted stock issued to
employees. The net impact of the Company’s issuances of stock and share repurchases during the nine months ended October 2, 2026 resulted in a net cash outflow of
$545 million.
During the nine months ended September 26, 2025, the total cash outflow for treasury stock purchases was $644 million. The Company repurchased 8.0 million shares of
common stock under the share repurchase plan authorized by our Board of Directors. These shares were repurchased at an average cost of $67.14 per share, for a total cost of
$534 million. In addition to shares repurchased under the share repurchase plan, the Company’s treasury stock activity included shares surrendered to the Company to pay the
exercise price and/or to satisfy tax withholding obligations in connection with stock swap exercises of employee stock options and/or the vesting of restricted stock issued to
employees. The net impact of the Company’s issuances of stock and share repurchases during the nine months ended September 26, 2025 resulted in a net cash outflow of
$401 million.
Dividends
During the nine months ended October 2, 2026 and September 26, 2025, the Company paid dividends of $6,842 million and $4,391 million, respectively. As a result of the
timing of our quarterly reporting periods as well as our dividend payment dates, the Company paid all of the 2026 third quarterly dividend in the third quarter and paid
substantially all of the 2025 third quarterly dividend in the fourth quarter.
Our Board of Directors approved the Company’s regular quarterly dividend of $0.53 per share at its October 2026 meeting. This dividend is payable on December 15, 2026 to
shareowners of record as of the close of business on December 1, 2026.
Proceeds from Sale of a Noncontrolling Interest
During the nine months ended September 26, 2025, the Company received proceeds of $1,277 million from the sale of a noncontrolling interest. Refer to Note 11 of Notes to
Consolidated Financial Statements for additional information.
Other Financing Activities
During the nine months ended October 2, 2026 and September 26, 2025, the total cash outflow for other financing activities was $13 million and $261 million, respectively.
The cash outflow during the nine months ended September 26, 2025 included $149 million of withholding taxes and other direct costs related to the sale of a noncontrolling
interest. Refer to Note 11 of Notes to Consolidated Financial Statements for additional information. Additionally, the cash outflow during the nine months ended September 26,
2025 included $104 million of the $6,173 million final milestone payment for fairlife.
47

-- 50 of 66 --

Foreign Exchange
Our international operations are subject to certain opportunities and risks, including currency fluctuations and governmental actions. We closely monitor our operations in each
country and seek to adopt appropriate strategies that are responsive to changing economic and political environments as well as to fluctuations in currencies.
Due to the geographic diversity of our operations, weakness in some currencies may be offset by strength in other currencies over time. Our hedging activities are designed to
mitigate, over time, a portion of the impact of exchange rate fluctuations on our net income. Taking into account the effects of our hedging activities, the impact of fluctuations
in foreign currency exchange rates increased our operating income for the three and nine months ended October 2, 2026 by 3% and 4%, respectively.
Based on current spot rates and our hedging coverage in place, we expect foreign currency exchange rate fluctuations will have a favorable impact on operating income and
cash flows from operating activities through the end of the year.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We have no material changes to the disclosures on this matter made in our Annual Report on Form 10-K for the year ended December 31, 2025.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company, under the supervision and with the participation of its management, including the Chief Executive Officer and the Chief Financial Officer, evaluated the
effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as
amended (“Exchange Act”)) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded
that the Company’s disclosure controls and procedures were effective as of October 2, 2026.
Changes in Internal Control Over Financial Reporting
There have been no changes in the Company’s internal control over financial reporting during the quarter ended October 2, 2026 that have materially affected, or are reasonably
likely to materially affect, the Company’s internal control over financial reporting.
Part II. Other Information
Item 1. Legal Proceedings
Information regarding reportable legal proceedings is contained in Part I, “Item 3. Legal Proceedings” in our Annual Report on Form 10-K for the year ended December 31,
2025, as updated in Part II, “Item 1. Legal Proceedings” in our Quarterly Report on Form 10-Q for the quarter ended April 3, 2026, and as further updated in Part II, “Item 1.
Legal Proceedings” in our Quarterly Report on Form 10-Q for the quarter ended July 3, 2026. The following updates and restates the description of the previously reported
U.S. Federal Income Tax Dispute matter and provides updates to a previously reported environmental matter. Management believes that, except as disclosed in “U.S. Federal
Income Tax Dispute” below, the total liabilities of the Company that may arise as a result of currently pending legal proceedings will not have a material adverse effect on the
Company taken as a whole.
U.S. Federal Income Tax Dispute
On September 17, 2015, the Company received a Notice from the IRS seeking approximately $3.3 billion of additional federal income tax for years 2007 through 2009. In
the Notice, the IRS stated its intent to reallocate over $9 billion of income to the U.S. parent company from certain of its foreign affiliates that the U.S. parent company
licensed to manufacture, distribute, sell, market and promote its products in certain non-U.S. markets.
The Notice concerned the Company’s transfer pricing between its U.S. parent company and certain of its foreign affiliates. IRS rules governing transfer pricing require arm’s-
length pricing of transactions between related parties such as the Company’s U.S. parent and its foreign affiliates.
To resolve the same transfer pricing issue for the tax years 1987 through 1995, the Company and the IRS had agreed in 1996 on an arm’s-length methodology for determining
the amount of U.S. taxable income that the U.S. parent company would report as compensation from its foreign licensees. The Company and the IRS memorialized this accord
in the Closing Agreement resolving that dispute. The Closing Agreement provided that, absent a change in material facts or circumstances or relevant federal tax law, in
calculating the Company’s income taxes going forward, the Company would not be assessed penalties by the
48

-- 51 of 66 --

IRS for using the agreed-upon tax calculation methodology that the Company and the IRS agreed would be used for the 1987 through 1995 tax years.
The IRS audited and confirmed the Company’s compliance with the agreed-upon Closing Agreement methodology in five successive audit cycles for tax years 1996 through
2006.
The September 17, 2015 Notice from the IRS retroactively rejected the previously agreed-upon methodology for the 2007 through 2009 tax years in favor of an entirely
different methodology, without prior notice to the Company. Using the new tax calculation methodology, the IRS reallocated over $9 billion of income to the U.S. parent
company from its foreign licensees for tax years 2007 through 2009. Consistent with the Closing Agreement, the IRS did not assert penalties, and it has yet to do so.
The IRS designated the Company’s matter for litigation on October 15, 2015. Litigation designation is an IRS determination that forecloses to a company any and all alternative
means for resolution of a tax dispute. As a result of the IRS’ designation of the Company’s matter for litigation, the Company was forced to either accept the IRS’ newly
imposed tax assessment and pay the full amount of the asserted tax or litigate the matter in the federal courts. The matter remains subject to the IRS’ litigation designation,
preventing the Company from any attempt to settle or otherwise mutually resolve the matter with the IRS.
The Company consequently initiated litigation by filing a petition in the Tax Court in December 2015, challenging the tax adjustments enumerated in the Notice.
Prior to trial, the IRS increased its transfer pricing adjustment by $385 million, resulting in an additional tax adjustment of $135 million. The Company obtained a summary
judgment in its favor on a different matter related to Mexican foreign tax credits, which thereafter effectively reduced the IRS’ potential tax adjustment by $138 million.
The trial was held in the Tax Court from March through May 2018, and final post-trial briefs were filed and exchanged in April 2019.
On November 18, 2020, the Tax Court issued the Opinion in which it predominantly sided with the IRS but agreed with the Company that dividends previously paid by the
foreign licensees to the U.S. parent company in reliance upon the Closing Agreement should continue to be allowed to offset royalties, including those that would become
payable to the Company in accordance with the Opinion. On November 8, 2023, the Tax Court issued a supplemental opinion, siding with the IRS in concluding both that
certain U.S. tax regulations (known as the blocked-income regulations) that address the effect of certain Brazilian legal restrictions on royalty payments by the Company’s
licensee in Brazil apply to the Company’s operations and that the Tax Court opinion in the 3M case controlled as to the validity of those regulations. On October 1, 2025, the
U.S. Court of Appeals for the Eighth Circuit issued an opinion reversing the judgment of the Tax Court in the 3M case. In its decision, the court concluded that the blocked-
income regulation was inconsistent with IRC Section 482 and that the IRS therefore could not reallocate income from 3M’s subsidiary in Brazil to 3M in contravention of
Brazilian restrictions on the payment of royalties. Further, the U.S. Court of Appeals for the Eighth Circuit specifically rejected the IRS’ argument that the ability of 3M’s
subsidiary in Brazil to pay dividends, rather than royalties, meant that royalty income should not be treated as blocked. Both of these conclusions are highly supportive of the
Company’s position in its case and reinforce its prior conclusions.
The Company believes that the IRS and the Tax Court misinterpreted and misapplied the applicable regulations in reallocating income earned by the Company’s foreign
licensees to increase the Company’s U.S. tax. Moreover, the Company believes that the retroactive imposition of such tax liability using a calculation methodology different
from that previously agreed upon by the IRS and the Company, and audited by the IRS for over a decade, is unconstitutional. The Company intends to assert its claims on
appeal and vigorously defend its positions. In addition, for its litigation with the IRS and for purposes of its appeal of the Tax Court decision, the Company continues to
evaluate the implications of several significant administrative law cases recently decided by the U.S. Supreme Court, most notably Loper Bright v. Raimondo, which overruled
the Chevron case. Since 1984, the Chevron case had required that courts defer to agency interpretations of statutes and agency action. In Ohio v. EPA and Garland v. Cargill,
two of the recent decisions, the U.S. Supreme Court demonstrated how courts are to rule on agency interpretations and actions without the deference previously required by the
Chevron case.
On August 2, 2024, the Tax Court entered a decision reflecting additional federal income tax of $2.7 billion for the 2007 through 2009 tax years. With applicable interest, the
total liability for the 2007 through 2009 tax years resulting from the Tax Court’s decision is $6.0 billion, for which the IRS issued the Company invoices on September 3, 2024.
The Company paid the IRS Tax Litigation Deposit on September 10, 2024, which stopped interest from accruing on the additional tax due for the 2007 through 2009 tax years.
That amount, plus interest earned, would be refunded in full or in part if the Company’s tax positions are ultimately sustained on appeal. For the three and nine months ended
October 2, 2026, the Company recorded net interest income of $57 million and $155 million, respectively, related to this tax payment. For the three and nine months ended
September 26, 2025, the Company recorded net interest income of $55 million and $162 million, respectively, related to this tax payment. These amounts were recorded in the
line item income taxes in our consolidated statements of income, in accordance with our accounting policy. The payment of the IRS invoices and the related accrued interest
were recorded in the line item
49

-- 52 of 66 --

other noncurrent assets in our consolidated balance sheets as of October 2, 2026 and December 31, 2025. On October 22, 2024, the Company appealed the Tax Court’s decision
to the U.S. Court of Appeals for the Eleventh Circuit. The Company filed its principal appellate brief with the U.S. Court of Appeals for the Eleventh Circuit on March 12,
2025. The IRS filed its appellate brief on July 7, 2025. The Company filed its reply brief on August 27, 2025. The U.S. Court of Appeals for the Eleventh Circuit heard the case
on June 25, 2026.
In determining the amount of tax reserve to be recorded as of December 31, 2020, the Company completed the required two-step evaluation process prescribed by Accounting
Standards Codification 740, Accounting for Income Taxes. In doing so, we consulted with outside advisors, and we reviewed and considered relevant laws, rules, and
regulations, including, but not limited to, the Opinions and relevant caselaw. We also considered our intention to vigorously defend our positions and assert our various well-
founded legal claims via every available avenue of appeal. We concluded, based on the technical and legal merits of the Company’s tax positions, that it is more likely than not
the Company’s tax positions will ultimately be sustained on appeal. In addition, we considered a number of alternative transfer pricing methodologies, including the Tax Court
Methodology, that could be applied by the courts upon final resolution of the litigation. Based on the required probability analysis, we determined the methodologies we believe
the federal courts could ultimately order to be used in calculating the Company’s tax. As a result of this analysis, we recorded a tax reserve of $438 million during the year
ended December 31, 2020 related to the application of the resulting methodologies as well as the different tax treatment applicable to dividends originally paid to the U.S.
parent company by its foreign licensees, in reliance upon the Closing Agreement, that would be recharacterized as royalties in accordance with the Opinions and the Company’s
analysis.
The Company’s conclusion that it is more likely than not the Company’s tax positions will ultimately be sustained on appeal is unchanged as of October 2, 2026. However,
based on the required probability analysis and the accrual of interest through the current reporting period, we updated our tax reserve as of October 2, 2026 to $538 million.
While the Company strongly disagrees with the IRS’ positions and the portions of the Opinions affirming such positions, it is possible that some portion or all of the
adjustments proposed by the IRS and sustained by the Tax Court could ultimately be upheld. In that event, the Company would not receive a refund of the applicable portion or
all of the $6.0 billion it paid in response to the IRS invoices issued in September 2024 and the related accrued interest receivable of $589 million as of October 2, 2026.
Additionally, the Company would likely be subject to significant additional liabilities for subsequent years, which could have a material adverse impact on the Company’s
financial position, results of operations and cash flows.
The Company calculated the potential impact of applying the Tax Court Methodology to reallocate income from foreign licensees potentially covered within the scope of the
Opinions for the 2010 through 2025 tax years, assuming such methodology were to be ultimately upheld by the courts, and the IRS were to decide to apply that methodology to
subsequent years, with consent of the federal courts. This impact would include taxes and interest accrued through December 31, 2025. The calculations incorporated the
estimated impact of correlative adjustments to the previously accrued transition tax payable under the 2017 Tax Cuts and Jobs Act. The Company estimates that the potential
aggregate remaining incremental tax and interest liability for the tax years 2010 through 2025 could be approximately $14 billion as of December 31, 2025. Additional income
tax and interest on any unpaid potential liabilities for the 2010 through 2025 tax years would continue to accrue until the time any such potential liability, or portion thereof,
were to be paid. The Company estimates the impact of the continued application of the Tax Court Methodology for the three and nine months ended October 2, 2026 would
increase the potential aggregate incremental tax and interest liability by approximately $450 million and $1.4 billion, respectively. We currently project the continued
application of the Tax Court Methodology in 2026, assuming similar facts and circumstances as of December 31, 2025 and reflecting changes enacted under the One Big
Beautiful Bill Act effective in 2026, would result in an incremental annual tax liability that would increase the Company’s effective tax rate by approximately 3.8%.
Environmental Matter
On June 20, 2024, the Mayor and City Council of Baltimore filed a lawsuit against the Company and several unrelated parties in the Circuit Court for Baltimore City, Maryland
(“Baltimore Circuit Court”), concerning the environmental impacts of plastic packaging on the city’s lands and waterways. The complaint asserts claims for (a) violations of
various state statutes and local ordinances that prohibit littering or improper dumping of waste on public or private property; (b) unfair, abusive or deceptive trade practices; (c)
trespass upon city property; (d) design defects; (e) public nuisance; (f) failure to warn; and (g) negligence. The complaint seeks injunctive relief, compensatory damages and
punitive damages but does not specify an amount of damages sought. The Company believes it has strong defenses to the claims. On July 21, 2025, the Baltimore Circuit Court
granted in part the Company’s Motion to Dismiss, dismissing with prejudice all claims except the public nuisance claim. On July 22, 2026, the court dismissed the remaining
public nuisance claim, and on August 18, 2026, the plaintiff filed a notice of appeal as to all claims. The appeal will proceed before the Appellate Court of Maryland.
50

-- 53 of 66 --

Item 1A. Risk Factors
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form
10-K for the year ended December 31, 2025, which could materially affect our business, financial condition or future results. The risks described in this report and in our
Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us, or that we currently deem to be
immaterial, could also materially adversely affect our business, financial condition or future results.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table presents information with respect to purchases of common stock of the Company made during the three months ended October 2, 2026 by the Company or
any “affiliated purchaser” of the Company as defined in Rule 10b-18(a)(3) under the Exchange Act:
Period
Total Number of Shares
Purchased
Average
Price Paid
Per Share
Total Number of
Shares Purchased as Part of the
Publicly
Announced Plan
Maximum Number
of Shares That May
Yet Be Purchased
Under the Publicly
Announced Plan
July 4, 2026 through July 31, 2026 	538,615 $ 	83.86 	536,300 	59,148,814
August 1, 2026 through August 28, 2026 	1,085,783 	88.60 	1,085,783 	58,063,031
August 29, 2026 through October 2, 2026 	1,110,655 	87.94 	1,110,145 	56,952,886
Total 	2,735,053 $ 	87.40 	2,732,228
The total number of shares purchased includes: (1) shares purchased, if any, pursuant to the plan described in footnote 2 below and (2) shares surrendered, if any, to the Company to pay the
exercise price and/or to satisfy tax withholding obligations in connection with stock swap exercises of employee stock options and/or the vesting of restricted stock issued to employees.
In February 2019, the Company publicly announced that our Board of Directors had authorized a plan (“2019 Plan”) for the Company to purchase up to 150 million shares of our common stock.
This column discloses the number of shares purchased, if any, pursuant to the 2019 Plan during the indicated time periods (including shares purchased pursuant to the terms of preset trading
plans meeting the requirements of Rule 10b5-1 under the Exchange Act).
Item 5. Other Information
During the fiscal quarter ended October 2, 2026, none of our Directors or officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1
trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K, except as follows:
Henrique Braun, Chief Executive Officer, adopted a Rule 10b5-1 trading arrangement on August 28, 2026 for the potential exercise of vested stock options and the associated
sale of up to 136,968 shares of common stock of the Company, subject to certain conditions. The arrangement’s expiration date is August 28, 2028, or such earlier date upon
which all transactions are completed. His trading plan was adopted during an open trading window.
Item 6. Exhibits
In reviewing the agreements included as exhibits to this report, please remember they are included to provide you with information regarding their terms and are not intended to
provide any other factual or disclosure information about the Company or the other parties to the agreements. The agreements contain representations, warranties, covenants
and conditions by or of each of the parties to the applicable agreement. These representations, warranties, covenants and conditions have been made solely for the benefit of the
other parties to the applicable agreement and:
• should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be
inaccurate;
• may have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not
necessarily reflected in the agreement;
• may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and
• were made only as of the date of the applicable agreement, or such other date or dates as may be specified in the agreement, and are subject to more recent developments.
Accordingly, these representations, warranties, covenants and conditions may not describe the actual state of affairs as of the date they were made or at any other time.
Additional information about the Company may be found elsewhere in this report and
1 	2
1
2
51

-- 54 of 66 --

the Company’s other public filings, which are available without charge through the Securities and Exchange Commission’s website at http://www.sec.gov.
EXHIBIT INDEX
Exhibit No.
(With regard to applicable cross-references in the list of exhibits below, the Company’s Current, Quarterly and Annual Reports are filed with the Securities and Exchange
Commission (“SEC”) under File No. 001-02217; and Coca-Cola Refreshments USA, LLC’s (formerly known as Coca-Cola Refreshments USA, Inc. and Coca-Cola
Enterprises Inc.) Current, Quarterly and Annual Reports are filed with the SEC under File No. 001-09300.)
3.1 	Certificate of Incorporation of the Company, including Amendment of Certificate of Incorporation, dated July 27, 2012 — incorporated herein by reference to
Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 28, 2012.
3.2 	By-Laws of the Company, as amended and restated through October 19, 2023 — incorporated herein by reference to Exhibit 3.2 to the Company’s Current Report
on Form 8-K filed on October 20, 2023.
4.1 	As permitted by the rules of the SEC, the Company has not filed certain instruments defining the rights of holders of long-term debt of the Company or
consolidated subsidiaries under which the total amount of securities authorized does not exceed 10% of the total assets of the Company and its consolidated
subsidiaries. The Company agrees to furnish to the SEC, upon request, a copy of any omitted instrument.
4.2 	Amended and Restated Indenture, dated as of April 26, 1988, between the Company and Deutsche Bank Trust Company Americas, as successor to Bankers Trust
Company, as trustee — incorporated herein by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on May 25, 2017.
4.3 	First Supplemental Indenture, dated as of February 24, 1992, to Amended and Restated Indenture, dated as of April 26, 1988, between the Company and Deutsche
Bank Trust Company Americas, as successor to Bankers Trust Company, as trustee — incorporated herein by reference to Exhibit 4.2 to the Company’s Current
Report on
Form 8-K filed on May 25, 2017.
4.4 	Second Supplemental Indenture, dated as of November 1, 2007, to Amended and Restated Indenture, dated as of April 26, 1988, as amended, between the
Company and Deutsche Bank Trust Company Americas, as successor to Bankers Trust Company, as trustee — incorporated herein by reference to Exhibit 4.3 to
the Company’s Current Report on Form 8-K filed on May 25, 2017.
4.5 	Form of Note for 1.125% Notes due 2027 — incorporated herein by reference to Exhibit 4.7 to the Company’s Registration Statement on Form 8-A filed on March
6, 2015.
4.6 	Form of Note for 1.625% Notes due 2035 — incorporated herein by reference to Exhibit 4.8 to the Company’s Registration Statement on Form 8-A filed on March
6, 2015.
4.7 	Form of Note for 1.100% Notes due 2036 — incorporated herein by reference to Exhibit 4.4 to the Company’s Registration Statement on Form 8-A filed on
September 2, 2016.
4.8 	Form of Note for 2.900% Notes due 2027 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 25,
2017.
4.9 	Form of Note for 1.250% Notes due 2031 — incorporated herein by reference to Exhibit 4.7 to the Company’s Current Report on Form 8-K filed on March 8,
2019.
4.10 	Form of Note for 2.125% Notes due 2029 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on September 9,
2019.
4.11 	Form of Note for 3.375% Notes due 2027 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on March 25,
2020.
4.12 	Form of Note for 3.450% Notes due 2030 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on March 25,
2020.
4.13 	Form of Note for 4.125% Notes due 2040 — incorporated herein by reference to Exhibit 4.7 to the Company’s Current Report on Form 8-K filed on March 25,
2020.
4.14 	Form of Note for 4.200% Notes due 2050 — incorporated herein by reference to Exhibit 4.8 to the Company’s Current Report on Form 8-K filed on March 25,
2020.
4.15 	Form of Note for 1.450% Notes due 2027 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 4, 2020.
4.16 	Form of Note for 1.650% Notes due 2030 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 4, 2020.
4.17 	Form of Note for 2.500% Notes due 2040 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on May 4, 2020.
4.18 	Form of Note for 2.600% Notes due 2050 — incorporated herein by reference to Exhibit 4.7 to the Company’s Current Report on Form 8-K filed on May 4, 2020.
4.19 	Form of Note for 2.750% Notes due 2060 — incorporated herein by reference to Exhibit 4.8 to the Company’s Current Report on Form 8-K filed on May 4, 2020.
52

-- 55 of 66 --

4.20 	Form of Note for 0.125% Notes due 2029 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.21 	Form of Note for 0.375% Notes due 2033 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.22 	Form of Note for 0.800% Notes due 2040 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.23 	Form of Note for 1.000% Notes due 2028 — incorporated herein by reference to Exhibit 4.7 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.24 	Form of Note for 1.375% Notes due 2031 — incorporated herein by reference to Exhibit 4.8 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.25 	Form of Note for 2.500% Notes due 2051 — incorporated herein by reference to Exhibit 4.9 to the Company’s Current Report on Form 8-K filed on September
18, 2020.
4.26 	Form of Note for 1.500% Notes due 2028 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on March 5,
2021.
4.27 	Form of Note for 2.000% Notes due 2031 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on March 5,
2021.
4.28 	Form of Note for 0.125% Notes due 2029 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on March 9,
2021.
4.29 	Form of Note for 0.500% Notes due 2033 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on March 9,
2021.
4.30 	Form of Note for 1.000% Notes due 2041 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on March 9,
2021.
4.31 	Form of Note for 2.250% Notes due 2032 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 5, 2021.
4.32 	Form of Note for 2.875% Notes due 2041 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 5, 2021.
4.33 	Form of Note for 3.000% Notes due 2051 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on May 5, 2021.
4.34 	Form of Note for 0.950% Notes due 2036 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 6, 2021.
4.35 	Form of Note for 0.400% Notes due 2030 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 17,
2021.
4.36 	Form of Note for 5.000% Notes due 2034 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 13,
2024.
4.37 	Form of Note for 5.300% Notes due 2054 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 13,
2024.
4.38 	Form of Note for 5.400% Notes due 2064 — incorporated herein by reference to Exhibit 4.6 to the Company’s Current Report on Form 8-K filed on May 13,
2024.
4.39 	Form of Note for 3.125% Notes due 2032 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on May 14,
2024.
4.40 	Form of Note for 3.500% Notes due 2044 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on May 14,
2024.
4.41 	Form of Note for 4.650% Notes due 2034 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on August 14,
2024.
4.42 	Form of Note for 5.200% Notes due 2055 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on August 14,
2024.
4.43 	Form of Note for 3.375% Notes due 2037 — incorporated herein by reference to Exhibit 4.4 to the Company’s Current Report on Form 8-K filed on August 15,
2024.
4.44 	Form of Note for 3.750% Notes due 2053 — incorporated herein by reference to Exhibit 4.5 to the Company’s Current Report on Form 8-K filed on August 15,
2024.
4.45 	Indenture, dated as of July 30, 1991, between Coca-Cola Refreshments USA, Inc. and Deutsche Bank Trust Company Americas, as trustee — incorporated herein
by reference to Exhibit 4.1 to Coca-Cola Refreshments USA, Inc.’s Current Report on Form 8-K dated July 30, 1991.
4.46 	First Supplemental Indenture, dated as of January 29, 1992, to the Indenture, dated as of July 30, 1991, between Coca-Cola Refreshments USA, Inc. and Deutsche
Bank Trust Company Americas, as trustee — incorporated herein by reference to Exhibit 4.01 to Coca-Cola Refreshments USA, Inc.’s Current Report on Form 8-
K dated January 29, 1992.
53

-- 56 of 66 --

4.47 	Second Supplemental Indenture, dated as of June 22, 2017, to the Indenture, dated as of July 30, 1991, as amended, among Coca-Cola Refreshments USA, Inc.,
the Company and Deutsche Bank Trust Company Americas, as trustee — incorporated herein by reference to Exhibit 4.3 to the Company’s Current Report on
Form 8-K filed on June 23, 2017.
4.48 	Third Supplemental Indenture, dated as of July 5, 2017, to the Indenture, dated as of July 30, 1991, as amended, among Coca-Cola Refreshments USA, Inc., the
Company and Deutsche Bank Trust Company Americas, as trustee — incorporated herein by reference to Exhibit 4.3 to the Company’s Current Report on Form 8-
K filed on July 6, 2017.
10.1 	Letter, dated September 4, 2026, from the Company to Rob Gehring.
10.2 	Deferred Cash Agreement between the Company and Rob Gehring, dated September 8, 2026.
31.1 	Rule 13a-14(a)/15d-14(a) Certification, executed by Henrique Braun, Chief Executive Officer of The Coca-Cola Company.
31.2 	Rule 13a-14(a)/15d-14(a) Certification, executed by John Murphy, President and Chief Financial Officer of The Coca-Cola Company.
32.1 	Certifications required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. Section 1350),
executed by Henrique Braun, Chief Executive Officer of The Coca-Cola Company, and by John Murphy, President and Chief Financial Officer of The Coca-Cola
Company.
101 	The following financial information from The Coca-Cola Company’s Quarterly Report on Form 10-Q for the quarter ended October 2, 2026, formatted in iXBRL
(Inline Extensible Business Reporting Language): (i) Consolidated Statements of Income for the three and nine months ended October 2, 2026 and September 26,
2025; (ii) Consolidated Statements of Comprehensive Income for the three and nine months ended October 2, 2026 and September 26, 2025; (iii) Consolidated
Balance Sheets as of October 2, 2026 and December 31, 2025; (iv) Consolidated Statements of Cash Flows for the nine months ended October 2, 2026 and
September 26, 2025; and (v) Notes to Consolidated Financial Statements.
104 	Cover Page Interactive Data File (the cover page XBRL tags are embedded within the iXBRL document and included in Exhibit 101).
54

-- 57 of 66 --

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
THE COCA-COLA COMPANY
(Registrant)
/s/ ERIN L. MAY
Date: 	October 28, 2026 	Erin L. May
Senior Vice President, Controller and Chief Accounting Officer
(Principal Accounting Officer)
55

-- 58 of 66 --

Exhibit 10.1
September 4, 2026
Rob Gehring
Dear Rob,
We are delighted to extend to you an offer for the position of EVP and President, North America Operating Unit, subject to your election by The Coca-Cola
Company Board of Directors. Your start date will be mutually agreed upon at a later date, and you will report directly to me. The information contained in this
letter provides the terms and compensation details of this position. All payments set forth below are subject to applicable taxes and withholding requirements.
• 	Your principal place of assignment will be Atlanta, Georgia.
• 	Your annual base salary for your new position will be USD 950,000.
• 	You will be eligible to participate in the Annual Incentive Plan. Your target annual incentive for your new position is 100% of your annual base pay. Any
payment will depend on both the business performance and your personal contributions. Awards are made at the discretion of the Talent and Compensation
Committee based upon recommendations by Senior Management. As a discretionary program, the performance factors, eligibility criteria, payment
frequency, award opportunity levels and other provisions are variable. The plan may be modified from time to time.
• 	You will be eligible to participate in The Coca-Cola Company’s long-term incentive (“LTI”) program. Awards are made at the discretion of the Talent and
Compensation Committee based upon recommendations by Senior Management. You will be eligible to receive LTI awards within guidelines for the level
assigned to your position and based upon your leadership potential to impact the company’s future growth. As a discretionary program, eligibility criteria,
award opportunity levels, the award timing, frequency, size and mix of award vehicles are variable.
• 	Following the start of your employment, management of The Coca-Cola Company will present to the Talent and Compensation Committee, at a regularly
scheduled meeting, a recommendation for special long-term incentive awards with an approximate aggregate value of USD 4,550,000, consisting of:
◦ 	USD 2,550,000 in Restricted Stock Units (RSUs), vesting in two equal tranches, with the anticipated vesting dates occurring approximately after
year 1 and year 2 of grant, subject to the terms and conditions of the applicable award agreement.
◦ 	USD 2,000,000 in Performance Share Units (PSUs), subject to a three-year performance period, the commencement and timing of which will be
determined based on your hire date.
◦ 	The number of RSUs and PSUs granted will be calculated using the 30-calendar-day average stock price of The Coca-Cola Company common
stock as of the first day of the month in which the awards are approved. Dividend equivalents will not be payable during the applicable restriction
period.
• 	If you forfeit your 2026 bonus for your time worked at Monster Beverage Corporation, following the Monster Beverage Corporation disclosure of 2026
annual incentive results, you will receive a one-time cash payment equal to the annual incentive amount you would have earned, but have forfeited, pro-
rated for the time you were employed by Monster Beverage Corporation in 2026. The terms of this payment will be governed solely by the terms of the
enclosed deferred cash agreement.

-- 59 of 66 --

Rob Gehring
September 4, 2026
Page 2
• 	You will receive a cash award in the amount of USD 100,000 paid to you the month following your hire date. Should you voluntarily terminate employment
with the Company for any reason, or if you are terminated because of a violation of the Company’s Code of Business Conduct, within 12 months of
payment, you must repay 100% of that payment in full within 60 days. If for any reason you do not return such payments, the Company will offset the
amount owed from any form of compensation due, including but not limited to, salary, bonus, and non-qualified compensation.
• 	You are eligible for certain relocation benefits. Following your acceptance, you will be contacted by your Relocation Consultant to review the details of these
benefits. Should you voluntarily terminate employment with the company for any reason, or if you are terminated as a result of a violation of the company’s
code of Business Conduct, within 12 months of your initial employment date, you must repay these monies in full within 60 days.
• 	You are expected to maintain share ownership pursuant to the company’s share ownership guidelines at a level equal to four times your base salary. As you
are new to the company, you will have until December 2031 to comply with this requirement. You will be asked to provide information in December each
year on your progress toward your ownership goal, and that information will be reviewed with the Talent and Compensation Committee of the Board of
Directors the following February.
• 	You will be eligible for the company’s Financial Planning Reimbursement Program which provides reimbursement of certain financial planning services, up
to USD 10,000, subject to taxes and withholding.
• 	You will be eligible for the Emory Executive Health benefit which includes a comprehensive physical exam and one-on-one medical and lifestyle
management consultation.
• 	You are required to enter into the Agreement on Confidentiality, Non-Competition, and Non-Solicitation, as well as the Agreement Covering Inventions,
Discoveries, Copyrightable Material, Trade Secrets, and Confidential Information, effective immediately.
This offer letter is provided as information and does not constitute an employment contract.
This offer letter is contingent upon your resignation from Monster Beverage Corporation.
Rob, I feel certain that you will find challenge, satisfaction and opportunity in this role as we start our journey together during this important time.
Sincerely,
/s/ Henrique Braun
Henrique Braun
Chief Executive Officer
cc: Margie Lewis
Executive Compensation
Advanced Care
I, Rob Gehring, accept this offer.
Signature: /s/ Rob Gehring
Date: 	September 9, 2026

-- 60 of 66 --

Exhibit 10.2
DEFERRED CASH AGREEMENT
The Coca-Cola Company (the "Company") hereby agrees to pay to the recipient named below (the “Recipient”) on the date set forth below (“Payment Date”)
the amount set forth below (the “Award”) in accordance with and subject to the terms, conditions and restrictions of this Agreement.
Name of Recipient: 	Rob Gehring
Award: 	$743,750 multiplied by the Performance Metric and prorated for time worked at Monster Beverage Corporation in
2026.
Payment Date: 	Within 30 days following Monster Beverage Corporation’s annual results disclosure in 2027.
Performance Metric: 	The percentage payout for 2026 of the Monster Beverage Corporation Annual Incentive Compensation Plan based
on performance against metrics and as described in the 2027 Proxy of Monster Beverage Corporation.
TERMS AND CONDITIONS OF THIS AGREEMENT
(1) 	If all of the conditions set forth in this Agreement are satisfied, the Award will be paid to Recipient on the Payment Date.
(a) Conditions for the Award.
1. The payment shall be made only if the Recipient is, and has continuously been, employed by the Company since the date of this
Agreement through the Payment Date. In addition, in the event that the Recipient voluntarily terminates employment for any reason or is
terminated for failing to comply with the Company’s Code of Business Conduct, any payments made within one year prior to the termination
shall be repaid to the Company. If reimbursement is not made within 30 days of separation, the Company may offset any payments due to
Recipient, including, not limited to, salary payments, vacation reimbursements, trailing pay, and non-qualified benefits by the amount owed
to the Company or any portion thereof.
2. The payment shall be made only if the Recipient does not receive a benefit from the Monster Beverage Corporation Annual Incentive
Compensation Plan for the 2026 performance year.
(b) Recipient shall have no rights to the Award, including but not limited to rights to transfer, pledge, or hypothecate the Award until the applicable
Payment Date.
(c) Recipient shall not be entitled to defer payment of any amounts under this Agreement.
(d) The Recipient shall indicate his or her acceptance of this Agreement by signing and returning this Agreement.
(e) The Company, in its sole discretion, may reduce the Award payable under this Agreement if it determines that a Recipient has failed to comply
with the Company’s Code of Business Conduct, or if the Recipient owes any money to the Company and has failed to repay such obligation.
(2) 	Each notice relating to this award shall be in writing. All notices to the Company shall be addressed to the Secretary, The Coca-Cola Company, One
Coca-Cola Plaza, Atlanta, Georgia 30313. All
1

-- 61 of 66 --

notices to the Recipient shall be addressed to the address of the Recipient specified on the face page of this Agreement. Either the Company or the
Recipient may designate a different address by written notice to the other. Written notice to said addresses shall be effective to bind the Company, the
Recipient and the Recipient's representatives and beneficiaries.
(3) The Award will be paid in cash less all applicable federal and state tax withholdings. The Recipient acknowledges that the ultimate liability for any and all
taxes is the responsibility and liability of the Recipient.
(4) The Recipient hereby agrees that (a) any change, interpretation, determination or modification of this Agreement by the Company shall be final and
conclusive for all purposes and on all persons including the Company and the Recipient; and (b) this Agreement shall not affect in any way the right of
the Company to terminate or change the employment of the Recipient.
(5) In the event the Recipient engages in a “Prohibited Activity” (as defined below), at any time during the term of the Agreement, or within one year after
termination of the Recipient’s employment from the Company, or within one year after the Payment Date, whichever occurs latest, the Award shall be
forfeited and, if applicable, any payments already made shall be repaid to the Company. If reimbursement is not made within 30 days of separation, the
Company may offset any payments due to Recipient, including, but not limited to, salary payments, vacation reimbursements, trailing pay, and non-
qualified benefits by the amount owed to the Company or any portion thereof.
Prohibited Activities are:
(a) Non-Disparagement – making any statement, written or verbal, in any forum or media, or taking any action in disparagement of the Company or
any Related Company or affiliate thereof, including, but not limited to, negative references to the Company or its products, services, corporate
policies, or current or former officers or employees, customers, suppliers, or business partners or associates;
(b) No Publicity – publishing any opinion, fact, or material, delivering any lecture or address, participating in the making of any film, radio broadcast or
television transmission, or communicating with any representative of the media relating to confidential matters regarding the business or affairs of
the Company which the Recipient was involved with during the Recipient’s employment;
(c) Non-Disclosure of Trade Secrets – failure to hold in confidence all Trade Secrets of the Company that came into the Recipient’s knowledge during
the Recipient’s employment by the Company or any Related Company, or disclosing, publishing, or making use of at any time such Trade Secrets,
where the term "Trade Secret" means any technical or non-technical data, formula, pattern, compilation, program, device, method, technique,
drawing, process, financial data, financial plan, product plan, list of actual or potential customers or suppliers or other information similar to any of
the foregoing, which (i) derives economic value, actual or potential, from not being generally known to and not being readily ascertainable by
proper means by, other persons who can derive economic value from its disclosure or use, and (ii) is the subject of efforts that are reasonable
under the circumstances to maintain its secrecy;
(d) Non-Disclosure of Confidential Information – failure to hold in confidence all Confidential Information of the Company that came into the
Recipient’s knowledge during the Recipient’s employment by the Company or any Related Company, or disclosing, publishing, or making use of
such Confidential Information, where the term "Confidential Information" means any data or information, other than Trade Secrets, that is valuable
to the Company and not generally known to the public or to competitors of the Company;
(e) Return of Materials – failure of the Recipient, in the event of the Recipient’s termination of employment for any reason, promptly to deliver to the
Company all memoranda, notes, records, manuals or other documents, including all copies of such materials and all documentation prepared or
produced in connection therewith, containing Trade Secrets or Confidential Information regarding the Company's business, whether made or
compiled by the
2

-- 62 of 66 --

Recipient or furnished to the Recipient by virtue of the Recipient’s employment with the Company or a Related Company, or failure promptly to
deliver to the Company all vehicles, computers, credit cards, telephones, handheld electronic devices, office equipment, and other property
furnished to the Recipient by virtue of the Recipient’s employment with the Company or a Related Company;
(f) Non-Compete – rendering services for any organization which, or engaging directly or indirectly in any business which, in the sole judgment of any
senior officer designated by the Company, is or becomes competitive with the Company;
(g) Non-Solicitation – soliciting or attempting to solicit for employment for or on behalf of any corporation, partnership, or other business entity any
employee of the Company with whom the Recipient had professional interaction during the last twelve months of the Recipient’s employment with
the Company; or
(h) Violation of the Company Policies – violating any written policies of the Company or the Recipient’s employer applicable to the Recipient, including
without limitation the Company’s insider trading policy.
(6) If any of the terms of this Agreement may in the opinion of the Company conflict or be inconsistent with any applicable law or regulation of any
governmental agency having jurisdiction, the Company reserves the right to modify this Agreement to be consistent with applicable laws or regulations.
(7) The Recipient consents to and acknowledges that:
(a) the Award is discretionary in nature;
(b) the Award is a potential bonus payment not paid in lieu of any cash salary compensation and not part of normal or expected compensation or
salary for any purposes, including, but not limited to, calculating any termination, severance, resignation, redundancy, end of service payments,
bonuses, long-service awards, life or accident insurance benefits, pension or retirement benefits or similar payments; and
(c) the Agreement set forth the entire understanding between the Recipient, the Company, and any Related Company regarding the Award and
supersedes all prior oral and written agreements pertaining to this award.
(8) 	This Agreement has been made in and shall be construed and enforced under and in accordance with the laws of the State of Delaware, USA.
THE COCA-COLA COMPANY
/s/ Tapaswee Chandele
Tapaswee Chandele
Executive Vice President & Global Chief People Officer
I have read the above Agreement and hereby accept the above award under the terms and conditions of this Agreement and I agree to be bound thereby and
by the actions of the Company.
Recipient /s/ Rob Gehring
Rob Gehring
Date: 	September 8, 2026
3

-- 63 of 66 --

Exhibit 31.1
CERTIFICATIONS
I, Henrique Braun, Chief Executive Officer of The Coca-Cola Company, certify that:
1. 	I have reviewed this quarterly report on Form 10-Q of The Coca-Cola Company;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;
(b) 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles;
(c) 	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) 	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter
(the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s
internal control over financial reporting; and
5. 	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s
auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial
reporting.
Date: 	October 28, 2026
/s/ Henrique Braun
Henrique Braun
Chief Executive Officer of The Coca-Cola Company

-- 64 of 66 --

Exhibit 31.2
CERTIFICATIONS
I, John Murphy, President and Chief Financial Officer of The Coca-Cola Company, certify that:
1. 	I have reviewed this quarterly report on Form 10-Q of The Coca-Cola Company;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) 	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during
the period in which this report is being prepared;
(b) 	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to
provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles;
(c) 	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) 	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter
(the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s
internal control over financial reporting; and
5. 	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s
auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) 	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) 	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial
reporting.
Date: 	October 28, 2026
/s/ John Murphy
John Murphy
President and Chief Financial Officer of The Coca-Cola Company

-- 65 of 66 --

Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of The Coca-Cola Company (“Company”) on Form 10-Q for the period ended October 2, 2026 (“Report”), I, Henrique Braun, Chief
Executive Officer of the Company and I, John Murphy, President and Chief Financial Officer of the Company, each certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) 	to my knowledge, the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) 	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ HENRIQUE BRAUN
Henrique Braun
Chief Executive Officer of The Coca-Cola Company
October 28, 2026
/s/ JOHN MURPHY
John Murphy
President and Chief Financial Officer of The Coca-Cola Company
October 28, 2026

-- 66 of 66 --